Quarterlytics / Healthcare / Medical - Healthcare Information Services / Computer Programs and Systems

Computer Programs and Systems

cpsi · NASDAQ Healthcare
Claim this profile
Ticker cpsi
Exchange NASDAQ
Sector Healthcare
Industry Medical - Healthcare Information Services
Employees 1001-5000
← All annual reports
FY2003 Annual Report · Computer Programs and Systems
Sign in to download
Loading PDF…
CPSI

Clear direction for healthcare information solutions

2 0 0 3   A N N U A L   R E P O R T

Financial Highlights
(in thousands, except per share data)

Years Ended 
December 31,

2003
$ 81,303
48,404
32,899

2002
$ 73,744
42,925
30,819

20,353

18,750

12,546
216
121
12,883
5,017
$ 7,866

$
$

0.75
0.75

12,069
190
362
12,621
1,971
$ 10,650

$
$

1.06
1.06

$ 12,621
4,577
$ 8,044
0.80
$
0.80
$

10,488
10,537

10,024
10,061

Total revenues
Cost of sales

Gross profit

Operating expenses

Operating income

Interest income, net
Other

Income before taxes
Provision for income taxes
Net income

Basic earnings per share
Diluted earnings per share

Pro Forma Income Data (1)
Income before taxes as reported
Pro forma provision for income taxes
Pro forma net income
Pro forma basic earnings per share
Pro forma diluted earnings per share

Weighted average shares outstanding:

Basic
Diluted

(1) Pro forma adjustments reflect the provision for income taxes as if the Company had been taxed as a C corporation for all

periods presented.

Revenues

0
5
1
,
2
3
$

0
3
5
,
0
5
$

2
2
2
,
9
4
$

6
6
6
,
9
5
$

4
4
7
,
3
7
$

3
0
3
,
1
8
$

Net Income (2)

7
2
3
,
3
$

3
1
6
,
5
$

5
6
0
,
3
$

9
4
4
,
5
$

4
4
0
,
8
$

6
6
8
,
7
$

Hospital Clients

5
8
2

7
2
3

2
6
3

0
0
4

4
4
4

0
9
4

1 0 0 , 0 0 0

8 0 , 0 0 0

6 0 , 0 0 0

4 0 , 0 0 0

2 0 , 0 0 0

1 0 , 0 0 0

8 , 0 0 0

6 , 0 0 0

4 , 0 0 0

2 , 0 0 0

5 0 0

4 0 0

3 0 0

2 0 0

1 0 0

98 99 00 01 02 03

98 99 00 01 02 03

98 99 00 01 02 03

(2) Net income for years 1998 through 2002 are pro forma for comparative purposes.

C P S I

2 0 0 3   A N N U A L   R E P O R T

1

D A V I D A .   D Y E
President and Chief Executive Officer

Dear Stockholders:

CPSI  is  much  more  than  a  hospital
software company.  CPSI is in the business
information  technology
of  providing 
products  and  services  to  community
hospitals,  thereby  enabling  them  to
effectively  and  efficiently  manage  their
financial  and  clinical  operations  so  that
they  can  focus  on  their  primary  business
objective, quality patient care.  

A Unique Approach – 

the Single Source Solution

There are several companies that strive to
provide  such  a  solution.    However,  CPSI 
is  unique  in  the  hospital  information
technology industry because of our ability
to  provide  our  hospital  clients  with  a
single  source  solution  for  all  of  their
information technology requirements.  We
provide 
in-house
integrated,  100% 
developed  software  for  every  functional
area of a hospital and for the entities that
our  hospitals  often  operate,  such  as
nursing homes, home health agencies, and
physician clinics.  We sell and support all
of  the  hardware  necessary  to  be  used  in
conjunction with our software.  From our
in  Mobile,  we  print  patient
offices 
statements,  send  electronic  insurance
claims,  and  even  manage  entire  business
office  operations 
for  some  of  our
customers.    CPSI  is  the  only  information
service  company  that  provides  all  these
services; our competition does not.  

In  2003,  we 
further  distinguished
ourselves from the other companies in our
field  by  enhancing  and  continuing  to
develop  our  single  source  solution.    For
example,  in  the  fourth  quarter,  CPSI
added  an  extremely  significant  software

2

C P S I

2 0 0 3   A N N U A L   R E P O R T

including 

radiologists, 

application to our product suite, a Picture
Archiving  and  Communications  System
(PACS).    This  module  allows  all  of  the
many  physicians  involved  in  a  patient’s
care, 
family
physicians,  consultative  physicians,  and
surgeons,  to  have  real  time  access  to
diagnostic quality digital radiology images,
such as MRI, CT, and ultrasound.  Why is
this  so  important  to  our  company?
Because  the  complete  CPSI  system  now
enables  a  hospital  to  have  not  only  a
paperless patient chart through the use of
our  clinical  applications  such  as  lab,
pharmacy,  and  nursing  point-of-care,  but
also a filmless chart, or in other words, a
record  all
fully  electronic  medical 
contained within the CPSI system.  Unlike
all of the other major hospital information
system  vendors,  CPSI  elected  to  develop
our  PACS  in-house  rather  than  acquiring
or  partnering  with  a  third-party  vendor.
CPSI  and  our  hospital  clients  will  benefit
from this decision for years to come.

Our  approach  to  building  and  servicing
our  products  and  services  internally  has
served  us  well  for  almost  25  years.    The
hospitals that choose CPSI as their hospital
information system partner appreciate the
value  of  dealing  with  a  single  source
vendor for all of their information system
requirements.  Their goals are consistent:

> provide clinicians with real time access
to clinical information from anywhere at
anytime,

> facilitate  the  seamless  movement  of
the
patient 
financial  and  clinical  departments,
resulting  in  the  elimination  of  lost

information  between 

charges  and  the  improvement  of  back
office efficiency,

> do away with the need for cumbersome
and  costly  interfaces  between  disparate
systems, and 

> have one phone number to call for any
and  all  of  their  information  technology
questions and problems. 

2003 – Challenging Yet Prosperous

reasons, 

of 
as  nurses 

2003  was  a  notably  difficult  year
financially  for  community  hospitals  for
several 
including  a  weak
Medicare  and  Medicaid  reimbursement
environment,  high  salary  costs  due  to  a
clinical
shortage 
nationwide 
and
such 
professionals 
pharmacists,  and  lower  than  anticipated
patient admissions.  The difficult year for
our target market led to a challenging year
for CPSI.  Many hospitals delayed making
significant 
technology
information 
purchases due to lack of available capital.
Although our company added a record 48
new hospital clients in 2003, most of these
hospitals  approved  purchases  for  the
minimum  amount  of  software  needed  to
begin  the  installation  of  an  integrated
system  and  postponed  expenditures  for
additional  products  that  we  believe  they
might  have  otherwise  purchased  to  meet
their operational and competitive needs.

We are pleased to report that, despite this
tough  environment,  CPSI  had  another
successful  year  financially.    Our  gross
revenue  increased  10%  over  2002,  while
our bottom line remained constant.  Cash
flow  from  operations  and  total  cash
collections reached record highs, eclipsing
net income and gross revenues, respectively,

We continue to believe that our strong cash
performance highlights both the quality of our
customer service and our conservative revenue
recognition practices.

“

”

for the year, which we feel is a remarkable
accomplishment.  We continue to believe
that our strong cash performance highlights
both  the  quality  of  our  customer  service
and  our  conservative  revenue  recognition
practices.    CPSI’s  revenue  growth  rate  for
the  last  five  and  10  years  ending  2003  is
20%.  We firmly believe that our company
is positioned to experience similar growth
going forward.  

Looking to the Long Term

created 

As  a  result  of 
the  new  Medicare
Prescription Drug Bill, community hospitals
looking  forward  to  substantially
are 
improved  Medicare 
reimbursement
beginning in 2004.  In the past, Medicare’s
payment 
a
formula  has 
disproportionate  burden  on  smaller,
community-based  hospitals,  which  also
typically depend on Medicare for a greater
share of their payer mix than larger, urban
facilities.  The new Medicare bill, however,
rectifies  some  of  this  imbalance,  raising
Medicare reimbursements to rural hospitals
by an estimated $25 billion over the next
ten years.  

Meanwhile, 
the  underutilization  of
information  technology  within  healthcare
remains  staggering.    For  example,  in  our
target market of hospitals with under 300
beds,  less  than  20%  have  a  point-of-care
nursing  documentation  system  and  fewer
than  5%  have  bedside  medication
verification,  PACS,  and  computerized
physician  order  entry  systems.    This
means  that  more  than  95%  of  the
community  hospitals  in  this  country  still
maintain  a  predominantly  paper  chart  as
opposed  to  an  electronic  medical  record.

C P S I

2 0 0 3   A N N U A L   R E P O R T

3

We believe that we are in the right place, at the right
time, and that we have the right expertise and
approach to be the leader in our market.

“

”

At  some  point  in  the  near  future,  it  will
become necessary for hospitals of all sizes
to be fully automated across the continuum
of  care  in  order  to  remain  competitive.
Clinicians and patients will demand access
to their medical information electronically,
and as HIPAA enforcement becomes more
of  a  priority,  the  security  and  record
keeping  necessary  for  compliance  will
force  hospitals  to  automate  and  to  do  so
with integration in mind. 

the  growing  need 

In  addition, 
for
information  technology  in  the  healthcare
industry  is  gaining  national  political  and
media attention.  The focus is primarily on
the  use  of  technology  to  improve  patient
safety  and  therefore  reduce  the  cost  of
healthcare  delivery.    CPSI’s  application
software is being used around the country
by  our  customers  to  enhance  quality
patient  care.    For  example,  many  of  our
clients utilize handheld devices with built
in barcode scanners to verify at the patient
bedside  that  the  patient  is  receiving  the
correct medication at the right dose and at
the  right  time,  greatly  reducing  the
possibility  of  a  medication  error.    Several
of  our  hospital  customers  have  installed
our  ChartLink™  product,  which  gives
physicians real time access to the patient’s
chart to review such critical information as
vital  signs,  lab  results,  and  radiology
reports.  After reviewing this information,
doctors  are  able  to  enter  and  sign
orders
medication 
electronically 
CPSI
using 
Computerized  Physician  Order  Entry
application.    This  software  checks  for
adverse  drug-to-drug  and  drug-to-allergy
interactions and eliminates the difficulty in

ancillary 
the 

and 

4

C P S I

2 0 0 3   A N N U A L   R E P O R T

interpreting  hand  written  orders,  both  of
which are proven patient safety benefits.

We  believe  that  as  the  financial  climate
among community hospitals improves and
as the demand for information technology
within  the  healthcare  industry  continues
to steadily increase, CPSI will remain in an
ideal  position  to  capitalize  from  the
combined forces of these trends.  Our plan
is  to  continue  to  lead  the  community
hospital marketplace through the addition
of new client hospitals to our system and
to continue to grow our recurring revenue
stream through the addition of statement,
electronic  billing,  and  business  office
outsourcing  services  with  our  existing
customers. 

We believe that we are in the right place, at
the right time, and that we have the right
expertise and approach to be the leader in
our  market.    This  combination,  we  are
convinced,  makes  CPSI  the  partner  of
choice  for  community  hospitals  and
positions our company to deliver increasing
value  to  you,  our  shareholders.    We
appreciate your commitment and support.

Sincerely,

David A. Dye
President and Chief Executive Officer

SECURITIES AND EXCHANGE COMMISSION 
WASHINGTON, D.C. 20549 
________________ 

FORM 10-K 
FOR ANNUAL AND TRANSITION REPORTS PURSUANT TO  
SECTIONS 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 

ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE  
ACT OF 1934 for the fiscal year ended December 31, 2003, or 

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE  
ACT OF 1934 for the transition period from                to                . 

Commission file number:  000-49796 

COMPUTER PROGRAMS AND SYSTEMS, INC. 
(Exact Name of Registrant as Specified in Its Charter) 

Delaware 
(State or Other Jurisdiction 
of Incorporation or Organization) 

6600 Wall Street, Mobile, Alabama 
(Address of Principal Executive Offices) 

74-3032373 
(I.R.S. Employer 
Identification No.) 

36695 
(Zip Code) 

(251) 639-8100 
(Registrant’s telephone number, including area code) 

Securities registered pursuant to Section 12(b) of the Act: 
Securities registered pursuant to Section 12(g) of the Act: 

None 
Common Stock, $.001 par value 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) 

of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant 
was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes 

  No 

Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K is not 

contained herein, and will not be contained, to the best of registrant's knowledge, in definitive proxy or information 
statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K  

Indicate by check mark whether the registrant is an accelerated filer (as defined in Exchange Act Rule 12b-2).  

Yes 

  No 

The aggregate market value of common stock held by non-affiliates of the registrant at June 30, 2003 was 

$124,242,050.   

As of March 10, 2004 the registrant had outstanding 10,489,849 shares of its common stock. 

DOCUMENTS INCORPORATED BY REFERENCE: 

Portions of the definitive Proxy Statement for the Annual Meeting of Computer Programs and Systems, Inc.’s 
stockholders to be held on May 13, 2004 are incorporated by reference into Part III of this report. 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
TABLE OF CONTENTS 

Item No.  

Page No. 

SPECIAL NOTE REGARDING FORWARD LOOKING STATEMENTS ..............................................  1 
PART I 

1. 

2. 
3. 
4. 

PART II 

Business .............................................................................................................................  2 
Overview................................................................................................................ 2 
Industry Dynamics................................................................................................. 2 
Our Solution........................................................................................................... 4 
Strategy .................................................................................................................. 4 
Our Products and Services ..................................................................................... 6 
System Implementation and Training.................................................................. 14 
Technology .......................................................................................................... 15 
Research and Development ................................................................................. 15 
Customers, Sales and Marketing ......................................................................... 16 
Competition ......................................................................................................... 17 
Internal Management Controls ............................................................................ 17 
Intellectual Property............................................................................................. 18 
Employees............................................................................................................ 18 
Executive Officers ..............................................................................................  19 
Company Website................................................................................................ 20 
Properties .........................................................................................................................  20 
Legal Proceedings............................................................................................................  20 
Submission of Matters to a Vote of Security Holders .....................................................  20 

5. 

6. 
7. 

7A. 

8. 
9. 

9A. 

Market for Registrant's Common Equity and Related   
Stockholder Matters  ........................................................................................................  21 
Selected Financial Data ...................................................................................................  22 
Management's Discussion and Analysis of Financial  
Condition and Results of Operations ..............................................................................   23 
Quantitative and Qualitative Disclosures about  
Market Risk.....................................................................................................................   39 
Financial Statements and Supplementary Data...............................................................   39 
Changes in and Disagreements with Accountants on  
Accounting and Financial Disclosure .............................................................................   56 
Controls and Procedures ................................................................................................... 56 

PART III 

10. 
11. 
12. 

13. 
14. 

Directors and Executive Officers of the Registrant ........................................................ 57* 
Executive Compensation ................................................................................................ 57* 
Security Ownership of Certain Beneficial Owners and Management 
and Related Stockholder Matters .................................................................................... 57* 
Certain Relationships and Related Transactions............................................................. 58* 
Principal Accountant Fees and Services ......................................................................... 58* 

PART IV 

15.  

Exhibits, Financial Statement Schedules and Reports on Form 8-K ...............................  59 
SIGNATURES..........................................................................................................................................   60 

*  Portions of the definitive Proxy Statement for the Annual Meeting of our stockholders to be held on  
May 13, 2004 are incorporated by reference in Part III of this Form 10-K. 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
SPECIAL NOTE REGARDING FORWARD LOOKING STATEMENTS 

This Annual Report on Form 10-K contains forward-looking statements within the meaning of 

the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995.  These forward-
looking statements can be identified generally by the use of forward-looking terminology and words such 
as "expects," "anticipates," "estimates," "believes," "predicts," "intends," "plans," "potential," "may," 
"continue," "should," "will" and words of comparable meaning.  Without limiting the generality of the 
preceding statement, all statements in this Annual Report relating to estimated and projected earnings, 
margins, costs, expenditures, cash flows, growth rates and future financial results are forward-looking 
statements.  We caution investors that any such forward-looking statements are only predictions and are 
not guarantees of future performance.  Certain risks, uncertainties and other factors may cause actual 
results to differ materially from those projected in the forward-looking statements.  Such factors may 
include:  

• 

• 
• 

•  overall business and economic conditions affecting the healthcare industry;  
• 
• 

saturation of our target market and hospital consolidations;  
changes in customer purchasing priorities and demand for information technology 
systems;  
competition with companies that have greater financial, technical and marketing 
resources than we have;  
failure to develop new technology and products in response to market demands;  
fluctuations in quarterly financial performance due to, among other factors, timing of 
customer installations;  
failure of our products to function properly resulting in claims for medical losses;  

• 
•  government regulation of our products and customers; and 
• 

interruptions in our power supply and/or telecommunications capabilities.   

For more information about the risks described above and other risks affecting us, see “Risk 

Factors” beginning on page 35 of this Annual Report.  We also caution investors that the forward-looking 
information described herein represents our outlook only as of this date, and we undertake no obligation 
to update or revise any forward-looking statements to reflect events or developments after the date of this 
Annual Report. 

 
 
 
 
 
 
 
 
 
PART I 

ITEM 1. 

BUSINESS 

Overview 

We are a healthcare information technology company that designs, develops, markets, installs and 
supports computerized information technology systems to meet the unique demands of small and midsize 
hospitals. Our target market includes acute care community hospitals with 300 or fewer beds and small 
specialty hospitals. We are a single-source vendor providing comprehensive software and hardware 
products, complemented by data conversion, complete installation and extensive support. Our fully 
integrated, enterprise-wide system automates the management of clinical and financial data across the 
primary functional areas of a hospital. In addition, we provide services that enable our customers to 
outsource certain data-related business processes which we can perform more efficiently. We believe our 
products and services enhance hospital performance in the critical areas of clinical care, revenue cycle 
management, cost control and regulatory compliance. From our initial hospital installation in 1981, we 
have grown to serve more than 490 hospital customers across 45 states and the District of Columbia. In 
2003, we generated revenues of $81.3 million from the sale of our products and services. 

Industry Dynamics   

The healthcare industry is the largest industry in the United States economy. The Centers for 

Medicare and Medicaid Services, or "CMS," has calculated that fiscal 2003 total healthcare expenditures 
in the United States were approximately $1.7 trillion, or approximately 15.3% of the U.S. gross domestic 
product. CMS estimates that by fiscal 2013 total U.S. healthcare spending will reach $3.4 trillion, or 
18.4% of the estimated U.S. gross domestic product.  

Hospital services represents one of the largest categories of total healthcare expenditures. 
According to CMS, in fiscal 2003 spending on hospital services amounted to $518.1 billion, or 30.9% of 
total healthcare expenditures. According to the American Hospital Association, there are approximately 
4,900 community hospitals in the United States, with approximately 4,100 in our target market of 
hospitals with 300 or fewer acute care beds. In addition, there is a market of small specialty hospitals that 
focus on discrete medical areas such as surgery, rehabilitation and psychiatry.   

Notwithstanding the size and importance of the healthcare industry within the United States 
economy, the industry is constantly challenged by changing economic dynamics, increased regulation and 
pressure to improve the quality of healthcare. These challenges are particularly significant for the 
hospitals in our target market due to their more limited financial and human resources. However, we 
believe healthcare providers can successfully address these issues with the help of advanced medical 
information systems. Specific examples of the challenges facing healthcare providers include the 
following.  

Changing Economic Dynamics.    The federal Balanced Budget Act of 1997, or "BBA," 
significantly lowered Medicare reimbursements for hospital services. These reductions were projected to 
total over $250 billion over five years. While the Budget Refinement Act of 1999 and the Benefits 
Improvement Act of 2000 lessened the impact of the BBA, aggregate federal reimbursement for hospital 
services is still significantly below pre-1997 levels. Additionally, the Medicaid program, which is a 
federal/state program managed by the individual states and dependent in part on funding from the states, 
is in crisis due to the increasing cost of healthcare and the detrimental effect of the lagging economy on 
state revenues.  As a result of the recent enactment of the Medicare Prescription Drug, Improvement and 
Modernization Act of 2003, however, community hospitals are looking forward to substantially improved 

2 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Medicare reimbursement beginning in 2004.  This new legislation is expected to raise Medicare 
reimbursements to rural hospitals by an estimated $25 billion over the next ten years.   

Health Insurance Portability and Accountability Act.    The federal Health Insurance Portability 

and Accountability Act of 1996, or "HIPAA," requires the implementation of national guidelines for 
information management by healthcare organizations. Among other things, HIPAA mandates uniform 
electronic transactions and code sets, improved data security and increased patient privacy.  Final 
regulations for privacy standards became effective in April 2003.  Final regulations for electronic 
transaction/code set standards were adopted in February 2002 and were to be effective in October 2003. 
CMS, however, is currently allowing providers and payers to continue utilizing non-compliant transaction 
code sets.  The length of this grace period has not yet been determined.  The final rules for security 
standards were published in February 2003, and covered entities have until April 2005 to comply with the 
new security standards.   

HIPAA continues to be a major influence as illustrated by the results of the 15th Annual HIMSS 

Leadership Survey sponsored by Superior Consultant Company.  Survey respondents consider HIPAA 
compliance more than any other matter as a top business issue that will affect healthcare in the next two 
years. Approximately 48% of respondents identified upgrading information technology systems to meet 
HIPAA requirements as the number one information technology priority for their organizations.  
Approximately 47% of respondents identified increased patient safety as their number one priority.  In 
addition, results of the Winter 2004 Healthcare Industry HIPAA Compliance Survey conducted by 
HIMSS and Phoenix Health Systems indicate that HIPAA readiness is still a serious concern.  While 
respondent hospitals are decreasing their HIPAA compliance budgets for 2004, the respondent hospitals 
are still budgeting significant dollars to address HIPAA concerns.  Vendors that offer information 
solutions utilizing a common architecture and database structure, such as CPSI, are well positioned to 
provide healthcare participants with effective solutions to the HIPAA requirements.   

Activism for Improved Clinical Care.    In November 1999, the Institute of Medicine published a 

report entitled "To Err is Human: Building a Safer Healthcare System." The report indicated that 
avoidable medical error is one of the top ten leading causes of death in the United States. The report also 
estimates that medical error may add as much as $14.5 billion of preventable cost to the healthcare 
industry. As a result of this study, automated medical information systems have been increasingly 
identified as a key to improving patient care and reducing medical errors. For example, the Leapfrog 
Group, a consortium of more than 100 public and private organizations including General Motors, 
General Electric, AT&T and IBM, recommends that its members utilize hospitals with certain automated 
medical information systems that are designed to limit medical errors. Moreover, California has adopted 
legislation requiring hospitals to use automated medical information systems. We believe hospitals 
utilizing fully integrated enterprise-wide medical information systems that allow professionals real-time 
access to information such as electronic charts, treatment protocols and pathways, pharmaceutical records 
and treatment schedules will be favored by large employers and government payers. 

While economic, regulatory and consumer pressures such as those described above have 
increased rapidly over the last several years, we believe healthcare organizations have historically 
underinvested in information technology and services compared to other industries. This underinvestment 
has caused healthcare providers to rely on non-integrated, complex and inefficient information systems. A 
hospital's failure to adequately invest in modern medical information systems could result in fewer patient 
referrals, cost inefficiencies, lower than expected reimbursement, increased malpractice risk and possible 
regulatory infractions. 

In the face of decreasing revenue and increasing pressure to improve patient care, healthcare 

providers are in need of management tools that (1) increase efficiency in the delivery of healthcare 

3 

 
 
 
 
 
 
 
 
 
 
 
 
 
services, (2) reduce medical errors, (3) effectively track the cost of delivering services so those costs can 
be properly managed and (4) increase the speed and rate of reimbursement. We believe the industry has 
begun to embrace information technology as a management tool, evidenced by the fact that approximately 
50% of the respondents to the 15th Annual HIMSS Leadership Survey referenced above predicted an 
increase in their organizations' information technology operating budgets during the next twelve months. 
We believe these dynamics will allow for future revenue growth.  

Our Solution 

We have tailored an information technology solution that effectively addresses the specific needs 
of small and midsize hospitals. Due to their smaller operating budgets, community hospitals have limited 
financial and human resources to operate manual or inefficient information systems. However, these 
hospitals are expected to achieve the same quality of care and regulatory compliance as larger hospitals, 
placing them in a particularly difficult operating environment. 

We believe that the CPSI solution meets this challenge. We provide fully integrated, enterprise-

wide, HIPPA compliant medical information systems and services that collect, process, retain and report 
data in the primary functional areas of a hospital, from patient care to clinical processing to administration 
and accounting. As a key element of our complete solution, we provide ongoing customer service through 
regular interaction with customers, customer user groups and extensive customer support. Further, we 
offer outsourcing services that allow customers to avoid some of the fixed costs of a business office. We 
are capable of providing a single-source solution for small and midsize hospitals, making us a partner in 
their initiatives to improve operations and medical care. 

Our customers continuously communicate with us through our support teams and through 

organized user groups, allowing us to continue to provide a state-of-the-art solution that meets their 
specific needs. By remaining sensitive and responsive to the ever-changing demands of our customers and 
regularly updating our products, we believe we provide an information technology solution that meets the 
needs of community hospitals. Our business has continued to grow because we have successfully 
addressed the needs of community hospitals for fully integrated enterprise-wide information systems that 
allow them to improve operating effectiveness, reduce costs and improve the quality of patient care. 

Strategy 

Our objective is to continue to grow as a leading provider of healthcare information technology 

systems and services to small and midsize hospitals by following the same strategy that we have 
successfully pursued for over twenty-four years, the key elements of which are described below. 

Deliver a Single-Source Solution.    When a customer purchases the CPSI system, we provide 

everything necessary for the customer to implement and use our system. We deliver the application 
software, computer hardware, peripherals, forms and supplies used in the comprehensive information 
network. Our installation teams work extensively with each customer to convert existing data to the new 
system, to install all of the necessary equipment and to train hospital personnel to use our system. After 
installation, our support teams answer and address customer questions and issues related to any aspect of 
the system. We also offer customers additional services such as business office outsourcing, electronic 
billing outsourcing and ISP services. We believe our single-source approach to delivering a complete 
information system makes our system easier and more convenient for customers to understand and 
manage, which results in greater customer satisfaction and retention. 

Provide Enterprise-Wide, Fully Integrated Software Applications.    We have developed all of our 
software products internally as part of our fully integrated system architecture. Our experience has taught 

4 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
us that using a fully integrated system in the primary functional areas of a hospital ensures compatibility 
among applications and avoids pitfalls associated with interfacing disparate systems. Our system utilizes 
one central database where information is stored and used by all of our software applications. With our 
single database model, our systems provide secure, real-time access to all information across multiple 
applications for all those needing such access, including physicians, nurses, laboratory technicians, 
pharmacists, clinicians and other users. The enterprise-wide, fully integrated nature of our system also 
allows customers to monitor user access to information for purposes of compliance with new federal and 
state privacy regulations. 

Maintain Commitment to Customer Oriented Operating Philosophy.    A key factor in our success 

has been our focus on customer service and support. We make available to our customers experienced 
support teams that can assist with any question or problem. We currently have a greater than one to one 
support staff to customer ratio.  Our support teams are extensively trained, and our employees are 
generally promoted from within so that they have a thorough knowledge of our system and a commitment 
to our culture. Because all of our customers use the same version of our system, our support teams can be 
more effective by maintaining a complete understanding of a single system. As part of our commitment to 
system support, we actively solicit customer feedback regarding ways in which we can improve the 
effectiveness and efficiency of our systems. To further this goal, we have organized our customers into a 
national user group to promote the exchange of information regarding our system and to identify product 
enhancements based on our customers' operational experiences. We believe our user group concept is a 
key component of our success by positively impacting customer satisfaction and retention and by 
enhancing product development and system functionality. We will continue to focus on our national user 
group as a key component to our goal of maintaining and growing our customer base and market share. 

Expand Presence in Target Market.    We will continue to target small to midsize domestic 

hospitals of 300 or fewer acute care beds. We believe this market of approximately 4,100 community 
hospitals nationwide has been traditionally overlooked and underserved by other healthcare technology 
companies. In addition, a number of our customers are small specialty hospitals that focus on discrete 
medical areas such as surgery, rehabilitation and psychiatry. We intend to continue gaining customers 
from this market segment. Our system can help these smaller hospitals reduce costs and increase their 
operating efficiencies. We believe our personalized marketing approach and emphasis on customer 
relationships are attractive to the management of these hospitals. We also believe our system is well-
suited to hospitals of this size because they typically demonstrate a greater commitment than larger 
hospitals to the concept of an enterprise-wide, fully integrated system. While 93% of our current 
customers are hospitals of 100 acute care beds or less, we believe there is a substantial opportunity in the 
future to increase our market share among hospitals with 100 to 300 acute care beds. In addition, we will 
continue to sell additional services and software products to our existing customers who have not 
purchased our complete package of services and software applications.  

Emphasize Recurring Revenue Opportunities.    In addition to revenues from new system 
installations, we are developing sources of recurring revenues. Our current principal source of recurring 
revenues is our support and maintenance fees paid by existing customers. As our customer base grows, 
our recurring revenues from support and maintenance fees should also grow. We believe growth in 
recurring revenues will also come from our outsourcing services, which we market to our existing 
customers as well as new customers. These services include electronic billing, patient statement 
processing, business office outsourcing, ISP services and web site hosting. We also provide our software 
products on an ASP basis. When we provide ASP services, we maintain a customer's computer server in 
our facility and provide our system to the customer through remote access. Instead of the one-time system 
purchase price, these customers pay a monthly fee for the term of the ASP customer agreement, 
generating recurring revenues. 

5 

 
 
 
 
 
 
 
 
 
 
Our Products and Services 

Recent Developments  

We completed development of the following new products during 2003, and initial installations in 

customer facilities occurred during the fourth quarter of 2003: 

ImageLinkTM. ImageLinkTM is a fully integrated medical imaging solution for the capture, 

manipulation, annotation and storage of high resolution digital radiologic images from multiple source 
modalities.  Designed to enhance the efficiency of diagnostic decision making, the system includes a full-
featured viewer with custom work lists organized to the requirements of individual radiologists.  This 
product receives digital images with accompanying information from various modalities including 
Computed Tomography, Magnetic Resonance Imaging, Ultrasound, Nuclear Medicine, Radiography and 
Computed Radiography.  ImageLinkTM fits seamlessly into the hospital’s information technology 
infrastructure by sharing patient and order information with existing patient care and clinical applications. 
 This real-time link allows the update of ImageLinkTM work lists, identification of the appropriate 
modality to be used, application of an electronic signature to “lock” the image and notification of 
completed orders.  The resulting annotated softcopy images offer the healthcare enterprise a more 
complete electronic medical record that provides clinicians with secure and immediate access to 
diagnostic images when and where they need them. 

Medical Practice Patient Charting.  The Medical Practice Patient Charting module expands the 

information available on-line to practitioners by providing for the capture of patient assessments and 
creation of a permanent electronic encounter record.  Medical Practice Patient Charting, in conjunction 
with existing document scanning and archival data repository products, produces a permanent electronic 
patient encounter record that can include virtually any information desired.  Designed to automate the 
clerical functions associated with patient assessments, the module provides physician practices with a 
flexible documentation solution that charts information in real-time and reduces the amount of paper that 
must be stored.  With Medical Practice Patient Charting, encounter information can be immediately and 
securely accessed on-line at the physician office or the hospital. 

Systems 

We offer a full array of software applications designed to streamline the flow of information to 

the primary functional areas of community hospitals in one fully integrated system. We intend to continue 
to enhance our existing software applications and develop new applications as required by evolving 
industry standards and the changing needs of our customers. Pursuant to our customer support 
agreements, we provide all of our customers with software enhancements and upgrades typically twice 
each year. See "--Support and Maintenance Services." These enhancements enable each customer, 
regardless of its original installation date, to have the benefit of the most advanced CPSI products 
available. Our software applications: 

• 

• 

• 

provide automated processes that improve clinical workflow and support clinical 
decision-making; 

allow healthcare providers to efficiently input and easily access the most current patient 
medical data in order to improve the quality of care and patient safety; 

integrate clinical, financial and patient information to promote efficient use of time and 
resources, while eliminating dependence on paper medical records; 

6 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
        
       
 
 
• 

• 

• 

provide tools that permit healthcare organizations to analyze past performance, model 
new plans for the future and measure and monitor the effectiveness of those plans; 

provide for rapid and cost-effective implementation, whether through the installation of 
an in-house system or through our ASP services; and 

increase the flow of information by replacing centralized and limited control over 
information with broad-based, secure access by clinical and administrative personnel to 
data relevant to their functional areas. 

Our software applications are grouped for support purposes according to the following functional 

categories: 

• 

• 

• 

• 

• 

Patient Management 

Financial Accounting 

Clinical 

Patient Care 

Enterprise Applications 

Due to the integrated nature of the CPSI system, our software applications are not marketed as 

distinct products, and our sales force attempts to sell all applications to each customer as a single product. 
New customers must purchase from us and install the core applications of patient management and 
financial accounting and all hardware necessary to run these applications. In addition to the core 
applications, customers may also acquire one or more of our clinical, patient care and enterprise 
applications. Approximately one-third of our customers have purchased a combination of applications 
that meet their enterprise-wide information technology needs.  

The general functional categories, as well as the software applications in each of these categories, 

are described below. 

Patient Management.    Our patient management software enables a hospital to identify a patient 
at any point in the healthcare delivery system and to collect and maintain patient information throughout 
the entire process of patient care on an enterprise-wide basis. The single database structure of our 
software permits authorized hospital personnel to simultaneously access appropriate portions of a patient's 
record from any point on the system. The patient management software performs the following functions: 

7 

 
 
 
 
 
         
 
        
         
         
         
         
         
 
 
 
 
 
Registration 

• 
records patient admissions, discharges and transfers 
•  manages patient status, room assignments and             

recurring charges 

•  keeps information available to all hospital personnel in 
formats designed for their particular requirements 

Patient Accounting 

• 

records patient charges and maintains accounts receivable 
information including aging, service charges and cash 
receipts 

Health Information   
Management 

Patient Index 

Electronic Claims 
Processing 

Medical Practice 
Management 

•  generates and processes insurance claims 

• 

• 

supports the operational needs of the modern medical 
records department including transcription, case 
indexing/abstracting and statistical reporting 

tracks deficiencies in a patient's chart and provides chart 
location information 

•  maintains a master index of hospital patients and provides 
immediate online access to patient financial and medical 
data associated with a patient stay 

•  provides a computer-to-computer link with intermediaries 
for Medicare and other payers for the submission of claims 

• 

• 

supports patient account management and insurance 
processing for single and multiple practices/clinics 

supports both hospital-based and remote practices/clinics 

We also offer the following optional products that may be purchased as part of our core patient 

management suite: 

Scheduling 

Managed Care 

Quality Improvement 

•  maintains all patient scheduling information 

• 

• 

tracks patients enrolled in managed care plans and 
conforms billing functions to such plans 

automates hospital-wide total quality management and 
reporting requirements for utilization activity, risk 
management, infection surveillance and all accreditation 
review functions 

Financial Accounting.    Our financial accounting software provides a variety of business office 
applications designed to efficiently track and coordinate information needed for managerial decision-making. 
The financial accounting software: 

8 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   
 
 
Executive Information 
System 

• 

summarizes daily financial transactions regarding patient 
revenues, receipts, census statistics and billing information 
for ready access by hospital administrators 

General Ledger 

•  provides timely, accurate, financial information generated 

from daily hospital operations 

• 

formats financial statements to the specifications of each 
user and is able to generate up to 999 different user-
defined reports 

Accounts Payable 

•  processes vendor invoices and payments and their related 

general ledger entries 

Payroll/Personnel 

• 

• 

calculates all employee wages and benefits for an 
unlimited number of salaried and hourly employees 

allocates employee time to user-defined cost centers 

Time and Attendance 

•  uses touch screen time clocks to eliminate manual time 

Electronic Direct 
Deposits 

Human Resources 

Budgeting 

Fixed Assets 

Materials Management 

entry 

• 

reduces effort of gathering employee time data and 
increases access of managers to such data 

•  makes time records more accurate by identifying 

employees through bar-coding and optional biometric 
fingerprint technology 

•  provides for computerized bank deposits to meet payroll 

and accounts payable needs 

•  provides for computerized employee files through 

document/image scanning and data entry 

• 

• 

• 

• 

• 
• 

allows for complete tracking of benefits and other 
employee data through a variety of user-defined reports 

tracks job applicant information to assist in the employee 
recruiting and hiring process 

allows for complete on-line budget preparation through 
computerized access to historical data 

allows access to information regarding hospital assets 
including locations and depreciation scheduling 

tracks the flow of materials throughout the hospital 

automates the process of inventory control, materials 
purchasing, stock requisitions and patient charging 

9 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Clinical.    Our clinical software automates record keeping and reporting for many clinical 
functions including laboratory, radiology, physical therapy, respiratory care, and pharmacy. These 
products eliminate tedious paperwork, calculations and written documentation while allowing for easy 
retrieval of patient data and statistics. Our clinical software: 

Laboratory Information 
Systems 

•  provides an interface to laboratory analytical instruments 
in order to transfer results to nurse stations, mobile point-
of-care systems and remote physician offices 

• 

allows users to receive orders from any designated 
location, process orders and report results and maintain 
technical, statistical and account information 

Laboratory Instrument  
Interfaces 

•  provides an automated solution for reviewing test results 

and completing patient orders 

Radiology Information  
Systems 

• 

• 

• 

• 

reduces the amount of required manual data entry thereby 
reducing the likelihood of human error 

reduces time to process laboratory specimens 

includes flash card printing, patient scheduling, 
transcription, patient indexing by X-Ray film number, 
film tracking and location 

receives patient data, patient locations and other 
interdepartmental communications support 

ImageLinkTM 

•  provides a complete picture archiving and 

communications system (PACS) with comprehensive 
functionality designed to fit seamlessly with our other 
applications 

• 

allows the realization of an electronic medical record 
complete with diagnostic images 

•  provides physicians real time access to diagnostic images 

via the internet through ChartLinkTM 

10 

 
 
 
 
   
 
 
 
 
 
Physical Therapy and  
Respiratory Care 

Pharmacy 

• 

communicates to nursing the appropriate procedures and 
patient preparation instructions from orders entered into 
the CPSI system 

•  keeps a journal of the orders received and processed 
•  handles a variety of processing tasks after a patient order 

is reviewed 

• 

• 

allows a department to customize its results to be sent 
back to nursing 

allows the hospital pharmacist to enter and fill physician 
orders 

•  performs all of the functions related to patient charging, 
general ledger upgrading, re-supply scheduling and 
inventory reduction/statistics maintenance 

• 

improves patient care by monitoring drug/drug and 
food/drug interactions, allergy contraindications, dosage 
ranges and duplicate therapy 

•  produces drug education information for each patient in an 

easy-to-read format 

Patient Care.    Our patient care applications allow hospitals to create computerized "patient files" 

in place of the traditional paper file systems. This software enables physicians, nurses and other hospital 
staff to improve the quality of patient care through increased access to patient information, assistance with 
projected care requirements and feedback regarding patient needs. Our software also addresses current 
safety initiatives in the healthcare industry such as the transition from written prescriptions and physician 
orders to computerized physician order entry. Our patient care software:  

Order Entry / Results 
Reporting 

automates the entry of patient charges 

reduces "lost" charges and mistakes due to legibility 

• 
• 
• 
•  provides interactive, real time status reports for orders 

increases efficiency of nursing stations 

Point-of-Care System 

• 

allows nurses to enter patient data into the network at the 
patient's bedside thereby eliminating the duplicate entry of 
information 

•  utilizes touch-screen and wireless technology 
•  makes patient information instantly available throughout 

the entire hospital system 

11 

 
 
 
 
 
 
    
 
 
 
Patient Acuity 

ChartLink TM 

Medication Verification 

Resident Assessment 
Instruments 

• 

• 

categorizes patients according to an assessment of the 
acuity of the illness, severity of the symptoms, and 
projected nursing dependency 

allows nurses to project the total character and amount of 
care that should be provided to each patient 

•  provides physicians with secure and interactive access to 

patient information through a hospital's website 

•  provides for computerized physician order entry including 

medication order entry 

•  verifies the accuracy of patient medication orders at a 
patient's bedside by comparing scans of patient and 
medication bar codes against the medication orders and 
history for that patient 

• 

• 

screens medication orders for possible patient allergies 
and/or drug interactions 

allows nursing staff to complete time consuming resident 
reporting requirements in an expeditious and efficient 
manner 

•  generates nursing care plans based on deficiencies in the 

resident reports 

Medical Practice Charting 

•  provides a permanent electronic encounter record for the 

physician office 

•  provides patient charting customized to the specific needs 

of each practice 

Medical Practice Access 

•  provides physicians and their office administrators with 

remote access to online, real time, secure patient data such 
as insurance and billing information, diagnosis and 
procedure coding, discharge summaries, pharmacy profiles 
and other clinical and administrative information 

Enterprise Applications.    We provide software applications that support the products described 
above and are useful to all areas of the hospital. These applications include: ad hoc reporting, automatic 
batch and real-time system backups, an integrated fax system, archival data repository, document 
scanning and Microsoft Office integration. 

Home Health Information System.    We offer a comprehensive information system for use in 

home healthcare, which system incorporates certain of the applications described above. This system is 
used primarily by hospitals with a CPSI information system that also have home health departments. Our 
home health system provides an advanced solution that includes both home care patient 
accounting/billing and remote home care documentation and care tracking. The system is designed, 
developed and regularly enhanced to meet the needs and regulatory requirements that challenge home 
healthcare. 

12 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Support and Maintenance Services 

After a customer installs a CPSI system, we provide software application support, hardware 

maintenance, continuing education and related services pursuant to a support agreement. The following 
describes services provided to customers using CPSI systems. 

Total System Support.    We believe the quality of continuing customer support is one of the most 
critical considerations in the selection of an information system provider. We provide hardware, technical 
and software support for all aspects of our system which gives us the flexibility to take the necessary 
course of action to resolve any issue. Unlike our competitors who use third-party services for hardware 
and software support, we provide a single, convenient and efficient resource for all of our customers' 
system support needs. In order to minimize the impact of a system problem, we train our customer service 
personnel to be technically proficient, courteous and prompt. Because a properly functioning information 
system is crucial to a hospital's operations, our support teams are available 24 hours a day to assist 
customers with any problem that may arise. Customers can also use the Internet to directly access our 
support system. This allows customers to communicate electronically with our support teams at any time. 
With approximately 522 employees who provide customer service and support, we currently have a 
greater than one to one support staff to customer ratio. 

User Group.    All of our customers are members of our user group from which we solicit 

feedback regarding our products. We host a national user group meeting annually. We have also 
organized several active regional user groups which meet on a semi-annual basis. These groups meet to 
discuss and recommend product modifications and improvements which they then evaluate and prioritize. 
Upon confirming that the desired improvements are technically feasible, we agree to allocate a significant 
amount of programming time each year to undertake the requested modification or improvement. The 
majority of our product enhancements originate from suggestions from our customers through the user 
group structure.  

Software Releases.    We are committed to providing our customers with software and technology 

solutions that will continue to meet their information system needs. To accomplish this purpose, we 
continually work to enhance and improve our application programs. As part of this effort, we typically 
release two software updates each year at no additional cost to our customers. We design these 
enhancements to be seamlessly integrated into each customer's existing CPSI system. The benefit of these 
enhancements is that each customer, regardless of its original installation date, uses the most advanced 
CPSI software available. Through this process, we can keep our customers up-to-date with the latest 
operational innovations in the healthcare industry as well as changing governmental regulatory 
requirements. Another benefit of this "one system" concept is that our customer service teams can be 
more effective in responding to customer needs because they maintain a complete understanding of and 
familiarity with the one system that all customers use. 

Purchasing a new information technology system requires the expenditure of a substantial amount 
of capital and other resources, and many customers are concerned that these systems will become obsolete 
as technology changes. Our periodic product updates eliminate our customers' concerns about system 
obsolescence. We believe providing this benefit is a strong incentive for potential customers to select our 
products over the products of our competitors.  

Hardware Replacement.    As part of our customer service effort, we are also committed to 
promptly replacing malfunctioning system hardware in order to minimize the effect of operational 
interruptions. By providing all hardware used in our system, we believe we are better able to meet and 
address all of the information technology needs of our customers.  

13 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Application Service Provider.    In some circumstances, we offer ASP services to customers via 
remote access telecommunications. As an application service provider, we store and maintain computer 
servers dedicated to specific customers which contain all of such customers' critical patient and 
administrative data. These customers access this information remotely through direct telecommunications 
connections with these servers. 

Internet Service Provider.    As part of our total information solution, we can provide Internet 

connection services to our customers. We also can provide web-site design and hosting services. 

Forms and Supplies.    We offer our customers the forms that they need for their patient and 

financial records, as well as their general office supplies. Furnishing these forms and supplies helps us to 
achieve our objective of being a one-source solution for a hospital's complete healthcare information 
system requirements. 

Outsourcing Services 

Electronic Billing.    We provide electronic billing for customers at prices competitive with other 

electronic billing vendors. Once a customer processes patient insurance claims in our system, we then 
perform the electronic billing function with no other participation by hospital staff. With this service, 
customers need not prepare billing files or maintain interfaces with third-party software, thereby saving 
the customer both time and money. 

Statement Processing.    Our customers may choose to have us prepare and distribute all patient 

billing statements. We use our knowledge of a customer's collection system to produce statements without 
requiring any actions on the part of the hospital data processing personnel. Because we can connect 
directly with a customer's system, the customer is not required to build and transfer files to us. All system 
enhancements are incorporated into the statement process without having to modify any third-party 
vendor interface. Like the electronic billing outsourcing, this service saves the customer both time and 
money.  

Business Office Outsourcing.    We offer customers the option of using us to perform their 

primary business office functions, including patient billing and accounts receivable management. Using 
this service allows customers to reduce costs by employing fewer full time administrative employees.  

System Implementation and Training 

Conversion Services.    When a customer purchases our system, we convert its existing data to the 

CPSI system. Our knowledge of hospital data processing, in conjunction with extensive in-house 
technical expertise, allows us to accomplish this task in a cost effective manner. When we install a new 
system, the data conversion has already occurred so that the system is immediately operational. Our goal 
is for each customer to be immediately productive in order not to waste time and money on the costly and 
inefficient task of maintaining the same data on parallel systems. Our services also relieve the hospital 
staff of the time-consuming burden of data conversion. 

Training.    In order to integrate the new system and to ensure its success, we spend 

approximately three weeks providing individualized training on-site at each customer's facility at the time 
of installation. We directly train all hospital users, including staff members and healthcare providers, 
during all hospital shifts in the use of hardware and software applications. In contrast, some of our 
competitors train only a hospital's training staff at an off-site location. We employ nurses and medical 
technicians in addition to our technical training staff in order to help us communicate more effectively 
with our customers during the training process. 

14 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Technology 

Operating Systems and Server Platform.    We utilize Intel-based servers running industry 
standard "open systems," including Unix and Microsoft Windows 2000 Server operating systems. 

ClientWare® Networking.    Our ClientWare® application integrates the UNIX and Microsoft 
operating systems. This integration brings together the strengths of both operating environments. The 
processing power of UNIX combined with the communication capabilities of Microsoft Windows creates 
an information system that allows the use of familiar "point and click" processing. This architecture also 
facilitates integration of other Microsoft software and provides expanded opportunities for the inclusion 
of new technologies without sacrificing system reliability or performance. 

Wireless Technology.    Traditional workstations were designed around access to electrical and 
network outlets. We now use wireless networking technology to connect computers to the CPSI system. 
This allows customers to use mobile computers and to place stationary computers in locations for 
optimum convenience and ease of use. We incorporate wireless laptop and hand held computers into our 
system. Convenient to carry and use, these mobile computers allow effective data collection and real-time 
access to patient information from practically anywhere in the hospital. Information efficiently collected 
will then be more quickly accessible by other caregivers throughout the hospital. 

Point-of-Care Stations.    Since 1990, we have used "point-of-care stations" which allow nurses 

to enter information into the system at a patient's bedside. These stations consist of compact computers on 
individual data entry stations that are lightweight, durable and easy to maneuver. We incorporate our 
wireless networking capabilities into these stations in order to provide extended range and mobility. 

Touch Sensitive Displays.    Data entry is made easier through the use of touch sensitive displays. 

With this technology work areas are free of the traditional keyboard and mouse associated with most 
personal computers. Touch screens are also more efficient for users who are not proficient in computer 
skills.  

Voice Transcription.    We offer voice transcription software capable of learning an individual 
physician's speech patterns. Computerized transcription stations can then transcribe documents dictated 
by physicians. The resulting reduction in time required to input patient data and prepare patient 
documents positively impacts the quality of patient care by providing caregivers with faster access to the 
most up-to-date patient information. 

Biometric Recognition.    As unique as each individual, a fingerprint cannot be duplicated, 

making it one of the most secure methods of verifying a person's identity. Because of the sensitivity of 
healthcare information and proposed federal security requirements, we have incorporated licensed 
fingerprint identification technology as an option for our systems. When a user signs on to the system, he 
or she must scan his or her fingerprint as well as enter a traditional password. The system rapidly 
responds with the confirmation or rejection of the user's identity. 

Research and Development 

We are continually working to improve and enhance the CPSI system and to develop new 
products and services for our system. The primary source of ideas for improvements to our products and 
services comes from our customers through our national user group. We believe our interaction with 
customers and their communication with each other is the most efficient way to learn about and respond 
to changes in the healthcare operating environment. This approach to research and development allows us 
to quickly adapt to technology advances and improve our products and services to better serve the needs 

15 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
of our customers. Our management and customer support and service teams play a significant role in 
product development by continually monitoring the needs and desires of our customers and our market. In 
addition to our customer support and service teams, we currently have five employees whose primary 
function is the development of financial and enterprise software products and ten employees whose 
primary function is the development of clinical software products. Finally, we currently have eight 
research and development employees whose dedicated function is to develop new uses for and 
applications of technology available in the marketplace. 

Customers, Sales and Marketing 

Target Market.    The target market for our information system consists of small and midsize 

hospitals of 300 or fewer acute care beds. In the United States, there are approximately 4,100 hospitals in 
this size range. In addition, we market our products to small specialty hospitals in the United States that 
focus on discrete medical areas such as surgery, rehabilitation and psychiatry. As of March 10, 2004, we 
had installed our system in over 490 facilities in 45 states and the District of Columbia. Our customers 
historically have consisted of hospitals with 100 or fewer acute care beds. Approximately 93% of our 
existing customers are hospitals of this size. Our goal is to increase sales to hospitals consisting of 100 to 
300 acute care beds while maintaining our competitive position in the under 100 bed market segment.  
The following table provides information about our current customer base as of March 10, 2004: 

Less than 100 beds  
100-200 beds 
201-300 beds 
Total 

Current CPSI 
Customers 
461 
30 
                3 
   494  

Percentage of 
CPSI Customers 
        93%         

       6 
       1 
      100% 

Sales Staff.    Most of our new customers are referrals from our existing customers, thereby 

reducing the need for a large sales force. Currently, we have 17 employees dedicated to direct sales, nine 
of whom concentrate on new prospects, and eight of whom are responsible for the sale of additional 
products and services to existing customers. We hire our sales representatives from our existing 
employees.  Our current sales representatives have an average of 9.5 years of prior experience in 
installation, training and customer support. While centrally based at our headquarters in Mobile, our sales 
representatives have defined geographic territories in the United States in which to target new customers. 
A significant portion of the compensation for all sales personnel is performance based. 

Marketing Strategy.    Our primary marketing strategy is to generate referrals from our existing 

customers and directly solicit potential users through presentations at industry seminars and trade shows. 
We also advertise in various healthcare industry trade publications. For hospitals that we have targeted as 
potential customers, most of our direct sales efforts involve site visits and meetings with hospital 
management. The typical sales cycle of a healthcare information system usually takes six to eighteen 
months from the time of initial contact to the signing of a contract. Therefore, we believe it is important 
for our sales staff to dedicate a substantial amount of time and energy to building relationships with 
potential new customers. We do not conduct extensive marketing activities and promotions because 
hospitals are easily identified, finite in number and generally send a request for proposal to vendors when 
they contemplate the purchase of a hospital information system. 

16 

 
 
 
 
 
 
             
 
 
 
     
 
 
 
 
Competition 

The market for our products and services is competitive, and we expect additional competition 

from established and emerging companies in the future. Our market is characterized by rapidly changing 
technology, evolving user needs and the frequent introduction of new products. We believe the principal 
competitive factors that hospitals consider when choosing between us and our competitors are: 

• 

• 

• 

• 

• 

• 

• 

product features, functionality and performance; 

level of customer service and satisfaction; 

ease of integration and speed of implementation; 

product price; 

knowledge of the healthcare industry; 

sales and marketing efforts; and 

company reputation. 

Our principal competitors are Medical Information Technology, Inc., or "Meditech," and 
Healthcare Management Systems, Inc., or "HMS." Meditech and HMS compete with us directly in our 
target market of small and midsize hospitals. These companies offer products and systems that are 
comparable to our system and address the needs of hospitals in the markets we serve. 

Our secondary competitors include McKesson Corporation, Quadramed Corp., Cerner 
Corporation and Siemens Corporation. These companies are significantly larger than we are, and they 
typically sell their products and services to larger hospitals outside of our target market. However, they 
will sometimes compete directly with us. We also face competition from providers of practice 
management systems, general decision support and database systems and other segment-specific 
applications, as well as from healthcare technology consultants. Any of these companies as well as other 
technology or healthcare companies could decide at any time to specifically target hospitals within our 
target market. 

A number of existing and potential competitors are more established than we are and have greater 

name recognition and financial, technical and marketing resources than we have. Products of our 
competitors may have better performance, lower prices and broader market acceptance than our products. 
We expect that competition will continue to increase. 

Internal Management Controls   

We have developed and maintain an automated enterprise management system which permits us 

to manage not only all of our internal management, accounting and personnel functions, but also all 
information relating to each customer's information system. Our system maintains detailed records of all 
information regarding each customer's system, including all system specifications, service history and 
customer communications, among other things. This internal control system helps us to more effectively 
respond to customer support needs through complete and current system information and through 
situation-based problem solving. 

17 

 
 
 
 
 
        
 
 
 
 
 
 
         
 
 
 
 
 
 
 
 
 
Intellectual Property 

We regard some aspects of our internal operations, software and documentation as proprietary, 

and rely primarily on a combination of contract and trade secret laws to protect our proprietary 
information. We believe, because of the rapid pace of technological change in the computer software 
industry, trade secret and copyright protection is less significant than factors such as the knowledge, 
ability and experience of our employees, frequent software product enhancements and the timeliness and 
quality of support services. We cannot guarantee that these protections will be adequate or that our 
competitors will not independently develop technologies that are substantially equivalent or superior to 
our technology. 

We do not believe our software products or other CPSI proprietary rights infringe on the property 
rights of third parties. However, we cannot guarantee that third-parties will not assert infringement claims 
against us with respect to current or future software products or that any such assertion may not require us 
to enter into royalty arrangements or result in costly litigation.  

Employees 

As of March 10, 2004, we had 651 employees, all but four of whom are located at our offices in 
Mobile, Alabama. Our employees can be grouped according to the following general categories: 416 in 
financial and clinical software services and support, 111 in information technology services and support, 
59 in programming, 29 in sales and marketing and 36 in administration. We have 23 employees who 
perform research and development activities. These employees are included within the functional areas of 
financial and clinical software services and support and information technology services and support. Our 
general practice is to recruit recent college graduates for entry-level positions and then promote these 
individuals within the organization to fill vacancies in higher positions. We also hire nurses and other 
medically-trained professionals in connection with our support services. 

Since 1991, we have maintained a non-qualified profit sharing plan under which all full-time 

employees with three years of uninterrupted service are eligible to participate, other than executive 
officers and commissioned salespeople. The plan is designed to provide each eligible employee with 
periodic cash bonuses based on our profitability. Each eligible employee receives a pro rata share of the 
amount of cash distributed under the profit sharing plan based on the amount of their base salary 
compared to the sum of the salaries of all participating employees. Our profit sharing plan is not a 
qualified plan for tax purposes or a guaranteed benefit. Contributions to the plan are made periodically at 
the discretion of the Board of Directors. During 2003, we distributed approximately $1.1 million under 
this profit sharing plan. We plan to continue to make distributions under the profit sharing plan based on 
our profitability.  

We are fortunate to have a high rate of employee retention, with our senior management having 

an average tenure in excess of 15 years. Our performance depends in significant part on our ability to 
attract, train and retain highly qualified personnel. None of our employees are represented by a labor 
union, and we believe our relations with our employees are good. 

18 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Executive Officers  

The Executive Officers of CPSI serve at the pleasure of the Board of Directors.  Set forth below 
is a list of the current Executive Officers of CPSI and a brief explanation of their principal employment 
during the last five (5) years. 

David A. Dye – President and Chief Executive Officer.  David A. Dye, age 34, has served as 
our President and Chief Executive Officer since July 1999. He was elected as a director in March 2002. 
Mr. Dye began his career with us in May 1990 as a Financial Software Support Representative. From that 
time until June 1999, he worked for us in various capacities, including as Manager of Financial Software 
Support, Director of Information Technology and most recently as our Vice President supervising the 
areas of sales, marketing and information technology. 

J. Boyd Douglas – Executive Vice President and Chief Operating Officer.  J. Boyd Douglas, 
age 37, has served as our Executive Vice President and Chief Operating Officer since July 1999. He was 
elected as a director in March 2002. Mr. Douglas began his career with us in August 1988 as a Financial 
Software Support Representative. From May 1990 until November 1994, Mr. Douglas served as Manager 
of Electronic Billing, and from December 1994 until June 1999, he held the position of Director of 
Programming Services. 

M. Stephen Walker – Vice President--Finance, Chief Financial Officer, Secretary and 
Treasurer.  M. Stephen Walker, age 54, has served as our Vice President--Finance, Chief Financial 
Officer, Secretary and Treasurer since July 1999. From February 1991 until June 1999, Mr. Walker 
served as our controller with primary responsibility for all of our accounting functions. 

Victor S. Schneider – Vice President--Sales and Marketing.  Victor S. Schneider, age 45, has 

served as our Vice President--Sales and Marketing since July 1999. Mr. Schneider is responsible for 
overseeing all of our sales and marketing efforts. Mr. Schneider began his career with us in June 1983 as 
Sales Manager. He served in that capacity until January 1997 when he was promoted to Sales Director. 

Mellissa A. Hammons – Vice President--Financial Software Services.   Mellissa A. Hammons, 

age 47, has served as our Vice President--Financial Software Services since July 1999. Ms. Hammons is 
responsible for overseeing all aspects of the installation and support of our financial software products. 
Since beginning her career with us in 1985 as a Financial Software Support Representative, Ms. 
Hammons has worked in various positions in our Financial Software Services Division including 
Manager and Director of that division. 

Thomas W. Peterson – Vice President--Clinical Software Services.  Mr. Peterson, age 52, has 
served as our Vice President--Clinical Software Services since July 1999. Mr. Peterson is responsible for 
overseeing all aspects of the installation and support of our clinical software products. Since beginning his 
career with us in 1988 as a Clinical Software Support Representative, Mr. Peterson has worked in various 
positions in our Clinical Software Services Division including Manager and Director of that division. 

Patrick A. Immel – Vice President--Information Technology Services.  Patrick A. Immel, age 
33, has served as our Vice President--Information Technology Services since January 2000. Mr. Immel is 
responsible for overseeing technical hardware and support and hardware research and development. Mr. 
Immel began his career with us in July 1993 as a Financial Software Support Representative. Since that 
time, Mr. Immel has served as a programmer, Manager of Technical Support and most recently as 
Director of Information Technology Services. 

19 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Company Website 

The Company maintains a website at http://www.cpsinet.com.  The Company makes available on 

its website, free of charge, its Annual Report on Form 10-K, Quarterly Reports on Form 10-Q, Current 
Reports on Form 8-K, and all amendments to those reports, as soon as it is reasonably practicable after 
such material is electronically filed with the Securities and Exchange Commission.  The Company is not 
including the information contained on or available through its website as a part of, or incorporating such 
information into, this Annual Report on Form 10-K. 

ITEM 2. 

PROPERTIES 

Our corporate headquarters and executive offices are located on approximately 28 acres in 

Mobile, Alabama. We occupy approximately 117,500 square feet of space in ten buildings. Our main 
building consists of approximately 66,000 square feet of space. We also have eight additional buildings 
each consisting of approximately 6,000 square feet. Each of these smaller buildings is designed to 
accommodate a team of employees assigned to install and support a particular software application. We 
also occupy a building consisting of approximately 3,500 square feet of space which houses our eight 
research and development employees dedicated to developing new uses for and applications of available 
technology.  

We lease approximately 16.5 acres and all of our buildings (other than the research and 
development building) from CP Investments, Inc., an Alabama corporation, the stockholders of which are 
John Morrissey, John Heyer, Bob O'Donnell, Elissa Stillings, Kevin P. Wilkins, Tabitha M. Wilkins 
Olzinski, Ellen M. Harvey, Michael K. Muscat, Jr. and Susan M. Slaton. All of these individuals are 
either stockholders of CPSI, or, in the case of Ms. Stillings, the spouse of a stockholder.  Our leases with 
CP Investments, Inc. expire at various times between April 2012 and June 2013. The research and 
development building is leased from DJK, LLC, a limited liability company owned by Dennis Wilkins, a 
principal stockholder and a director of CPSI. Our lease with DJK, LLC also expires in April 2012. We 
also own 11.3 acres of undeveloped real property adjacent to our primary premises in order to 
accommodate future growth.  

          We believe our existing facilities will be sufficient to meet our needs until the end of 2004. At that 
time we believe we will need to construct additional facilities on the undeveloped portion of our campus 
in order to accommodate our expansion needs.  

ITEM 3. 

LEGAL PROCEEDINGS 

From time to time, we are involved in routine litigation that arises in the ordinary course of 

business.  We currently are involved in a litigated dispute relating to the installation of a hospital 
information system that, if resolved unfavorably, could have a negative impact on our quarterly earnings 
at some point in the future.  However, this dispute should not have a material adverse effect on our 
business or financial condition.  We are not currently involved in any other litigation that we believe 
could reasonably be expected to have a material adverse effect on our business, financial condition or 
results of operations. 

ITEM 4. 

SUBMISSION OF MATTERS TO A VOTE OF SECURITY-HOLDERS 

None. 

20 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
PART II 

ITEM 5. 

MARKET FOR REGISTRANT'S COMMON EQUITY AND RELATED 
STOCKHOLDER MATTERS 

Market for CPSI Common Stock 

At March 10, 2004, CPSI had 83 stockholders of record (which does not include the number of 

beneficial owners whose shares are held in "street" names by nominees who are record holders) and 
10,489,849 shares of CPSI common stock outstanding.   

CPSI common stock is traded in the over-the-counter market and prices are quoted on the 

NASDAQ Stock Market under the symbol "CPSI."  The reported sales price range for CPSI common 
stock during all four quarters of 2003 and the third and fourth quarters of 2002 (the first two quarters after 
the completion of our initial public offering (“IPO”) in May 2002) are shown below: 

Fiscal Year Ended 
December 31, 2003 

Fiscal Year Ended 
December 31, 2002 

Quarter 

High 

Low 

Quarter 

  High 

Low 

First 

Second 

Third 

Fourth 

$25.93 

$20.78

First  

17.80  

Second 

--

--

-- 

-- 

14.04  

Third  

$25.25  

$17.35 

14.40  

Fourth 

26.85  

19.00 

25.05 

21.75 

20.35 

The last reported sales price of CPSI Common Stock as reported on the NASDAQ Stock Market 

on March 10, 2004 was $18.35.     

Dividends 

During 2002, we paid a total of $16.9 million to our pre-IPO stockholders in connection with the 

IPO and our related conversion from an S corporation to a C corporation.  During 2003, we paid an 
additional $250,000 to these pre-IPO stockholders. 

During the second quarter of 2003, we paid our first dividend on our common stock to our post-
IPO stockholders.  In the second, third and forth quarters of 2003, we paid a dividend in the amount of 
$0.085 per share.  On February 3, 2004, we announced a dividend for the first quarter of 2004 in the 
amount of $0.12 per share.  We believe that paying dividends is an effective way of providing an 
investment return to our stockholders and a beneficial use of our cash.   

21 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
ITEM 6. 

SELECTED FINANCIAL DATA 

2003 

2002 

2001 

2000 

1999 

Year ended December 31,  

INCOME DATA: 
Total sales revenues 
Total costs of sales 
Gross profit 
Total operating expenses 
Operating income 
Total other income 
Income before taxes 
Income taxes 
Net income 

 $      81,303 
         48,405 
         32,898 
         20,352 
         12,546 
            338 
         12,884 
           5,018 
 $        7,866 

(in thousands except for share and per share data)
   $    49,222 
         31,487 
         17,735 
         13,080 
           4,655 
             236 
           4,891 
               -
   $      4,891 

$      73,744 
        42,925 
         30,819
        18,750 
        12,069 
            552 
        12,621 
          1,971 
$      10,650 

$    59,666 
      36,242 
      23,424 
      14,948 
        8,476 
          204 
        8,680 
               - 
$      8,680 

$    50,530 
      29,895 
      20,635 
      11,894 
         8,741 
          196 
        8,937 
               -
$      8,937 

Net income per share - basic 

$         0.75 

$         1.06 

 $       0.93 

   $       0.53 

$       0.96 

Net income per share - diluted 

$         0.75 

$         1.06 

$       0.93 

   $       0.53 

$       0.96 

Weighted average shares 
outstanding: 
 Basic 
 Diluted 

Pro forma income data: 
Historical income before taxes 
Pro forma income taxes 
Pro forma net income 

Pro forma net income per share – 
basic 

Pro forma net income per share – 
diluted 

BALANCE SHEET DATA 
Cash and cash equivalents 
Working capital 
Total assets 
Total current liabilities 
Note payable 
Total stockholders' equity 

   10,488,406 
10,536,929 

  10,024,438 
  10,061,765 

  9,288,000 
  9,288,000 

    9,288,000 
    9,288,000 

  9,288,000 
  9,288,000 

$      12,621 
          4,577 
$        8,044 

$      8,680 
        3,231 
$      5,449 

  $      4,891 
           1,826 
   $      3,065 

$      8,937 
        3,324 
$      5,613 

$         0.80 

$       0.59 

 $       0.33 

$       0.60 

$         0.80 

$       0.59 

 $       0.33 

$       0.60 

2003 

2002 

2001 

2000 

1999 

As of December 31,  

(in thousands) 

 $        9,473 
         19,610 
         31,204 
           5,452 
               -
         25,752 

$        6,352 
        14,812 
        28,909 
          8,430 
               -
        20,479 

$      2,019 
        5,667 
      17,251 
        6,551 
          664 
      10,036 

   $      1,033 
           4,658 
         14,515 
           5,810 
             749 
           7,956 

$        980 
        6,735 
      14,374 
        4,421 
          889 
        9,065 

(1) 

(2) 

CPSI operated as an S corporation through May 20, 2002 and, as such, was not subject to federal and 
certain state income taxes. 
Pro forma information reflects the provision for income taxes that would have been recorded had CPSI 
been a C corporation during all of the periods presented. 

22 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
ITEM 7. 

MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL 
CONDITION AND RESULTS OF OPERATIONS 

You should read the following discussion of our financial condition and results of operations in 
conjunction with "Selected Financial Data" and our financial statements and the related notes included 
elsewhere in this Annual Report. This discussion and analysis contains forward-looking statements that 
involve risks, uncertainties and assumptions. Our actual results may differ materially from those 
anticipated in these forward-looking statements as a result of many factors, including but not limited to 
those set forth under "Risk Factors" and elsewhere in this Annual Report. 

Background 

CPSI was founded in 1979 and specializes in delivering comprehensive healthcare information 
systems and related services to community hospitals. Our systems and services are designed to support 
the primary functional areas of a hospital and to enhance access to needed financial and clinical 
information. Our comprehensive system enables healthcare providers to improve clinical, financial and 
administrative outcomes. Our products and services provide solutions in key areas, including patient 
management, financial management, patient care and clinical, enterprise and office automation. 

We sell a fully integrated, enterprise-wide financial and clinical hospital information system 
comprised of all necessary software, hardware, peripherals, forms and office supplies, together with 
comprehensive customer service and support. We also offer outsourcing services, including electronic 
billing submissions, patient statement processing and business office functions, as part of our overall 
information system solution.   

Our system currently is installed and operating in over 490 hospitals in 45 states and the District 
of Columbia. Our customers historically have consisted of community hospitals with 100 or fewer acute 
care beds. However, we also serve and are targeting for growth the market consisting of hospitals with 
100 to 300 acute care beds. 

Overview 

We have achieved a compounded annual growth rate in revenues of approximately 20.0% over 

the past five years.  We did not achieve this growth rate in 2003, which we believe is the result of factors 
that affected our industry.  2003 was a notably difficult year financially for community hospitals for 
several reasons, including a weak Medicare and Medicaid reimbursement environment, high salary costs 
due to a nationwide shortage of clinical professionals such as nurses and pharmacists, and lower than 
anticipated patient admissions.  The difficult year for our target market led to a challenging year for CPSI. 
 Many hospitals delayed making significant information technology purchases due to lack of available 
capital.  Although we added a record 48 new hospital clients in 2003 (ordinarily a positive performance 
indicator), most hospitals approved purchases for the minimum amount of software needed to begin the 
installation of an integrated system.  These smaller purchases caused the size of our average installation 
contract (another key performance indicator for our business) to decrease from approximately $650,000 in 
2002 to approximately $500,000 in 2003. 

Despite this challenging environment, we had another successful year financially.  Our gross 
revenues increased ten percent over 2002, while our bottom line remained constant.  Cash flow from 
operations and total cash collections reached record highs, eclipsing net income and gross revenues, 
respectively, for the year.  We continue to believe that our strong cash performance reflects both the 
quality of our customer service and our conservative revenue recognition practices.  Also, our “win rate” 
in competing against other companies for sales to new hospitals continued to be very strong in 2003, 

23 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
exceeding the rate we achieved in 2002.  This is a key performance indicator that we look at in assessing 
the strength of our business from a competitive standpoint, and our results in 2003 strongly support the 
confidence we have in our business and the quality of the products and services we offer. 

As a result of the Medicare Prescription Drug, Improvement, and Modernization Act of 2003, 

community hospitals are looking forward to substantially improved Medicare reimbursement beginning in 
2004.  In the past, Medicare’s payment formula has created a disproportionate burden on smaller, 
community-based hospitals, which also typically depend on Medicare for a greater share of their payer 
mix than larger, urban facilities.  The new medicare legislation rectifies some of this imbalance, raising 
Medicare reimbursements to rural hospitals by an estimated $25 billion over the next ten years.  We 
believe that once community hospitals begin to feel the financial effects of this legislation, we will be in a 
good position to continue to grow our business. 

Revenues 

System Sales.    Revenues from system sales are derived from the sale of information systems 

(including software, conversion and installation services, hardware, peripherals, forms and office 
supplies) to new customers and from the sale of new or additional products to existing customers. We do 
not record revenue upon execution of a sales contract. Upon signing a contract to purchase a system from 
us, each customer pays a non-refundable 10% deposit that is recorded as deferred revenue. The customer 
then pays 40% of the purchase price for the software and the related installation, training and conversion 
when we install the system and commence training on-site at the customer's facility, which is likewise 
recorded as deferred revenue. When the system begins operating in a live environment, the remaining 
50% of the system purchase price is payable, and we recognize revenue for the total amount of the 
purchase price for software and related services. Revenues derived from installation of additional 
software applications are generally recognized upon installation. Revenues from the sale of hardware, 
forms and supplies are recognized upon the shipment of the product to the customer. 

Support and Maintenance.  We also derive revenues from the provision of system support 
services, including software application support, hardware maintenance, continuing education and related 
services. Support services are provided pursuant to a support agreement under which we provide 
comprehensive system support and related services in exchange for a monthly fee based on the services 
provided. The initial term of these contracts ranges from one to seven years, with a typical duration of 
five years. Upon expiration of the initial term, these contracts renew automatically from year-to-year 
thereafter until terminated. Revenues from support services are recognized in the month when these 
services are performed. 

We provide our products to some customers as an application service provider, or "ASP." We 
provide ASP services on a remote access basis by storing and maintaining servers at our headquarters 
which contain customers' patient and administrative data. These customers then access this data remotely 
in exchange for a monthly fee. In addition, as part of our total information solution, we also serve as an 
Internet service provider, or "ISP," for some of our customers for a monthly fee. We also provide web-site 
design and hosting services if needed. Revenues from our ASP and ISP services are recognized in the 
month when these services are delivered.  

Outsourcing Revenues.    We began offering outsourcing services in January 1999. Revenues 
from outsourcing services have increased rapidly since that time. We expect outsourcing revenues to 
continue to grow at a faster rate than our systems and services revenues.  Our outsourcing services include 
electronic billing, statement processing and business office outsourcing (primarily accounts receivable 
management). All of these outsourcing services are sold pursuant to one year customer agreements, with 

24 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
automatic one year renewals until terminated. Revenues from outsourcing services are recognized when 
these services are performed. 

Costs of Sales 

System Sales.    The principal costs associated with the design, development, sale and installation 
of our systems are employee salaries, benefits, travel expenses and certain other overhead expenses. For 
the sale of equipment we incur costs to acquire these products from the respective distributors or 
manufacturers, as the case may be. Costs are deferred and recognized as an expense at the time the related 
revenues are recognized on a completed contract basis. However, at December 31, 2003, 2002 and 2001, 
no system sales related costs were deferred as all contracts were deemed to be substantially complete, or 
such amounts were not considered to be material.  

Support and Maintenance.    The principal costs associated with our system support and 

maintenance services are employee salaries, benefits and certain other overhead expenses. Costs are 
expensed as incurred and are not deferred.  

We have the same employee groups providing both system installations and support and 

maintenance services. Salary related expenses are allocated between cost of system sales and cost of 
support and maintenance services based upon an estimate of the percentage of time employees spend 
performing each function.  

Outsourcing.    The principal cost related to our statement outsourcing is postage. The principal 

costs related to our electronic billing outsourcing are employee related expenses, such as salaries and 
benefits, and long distance telecommunication fees.  Supplies and forms are additional significant costs 
associated with our outsourcing services. Costs are expensed as incurred and are not deferred. 

25 

 
 
 
 
 
 
 
 
 
 
 
 
Results of Operations 

The following table sets forth certain items included in our results of operations for each of the 
three years in the period ended December 31, 2003, expressed as a percentage of our total revenues for 
these periods: 

INCOME DATA: 
Sales revenues: 
 System sales 
 Support and maintenance 
 Outsourcing 

Total sales revenues 

Costs of sales: 
 System sales 
 Support and maintenance 
 Outsourcing 

Total costs of sales 
Gross profit 

Operating expenses: 
 Sales and marketing 
 General and administrative 

Total operating expenses 
Operating income 

Other income (expense): 

 Interest income 
 Miscellaneous income 
 Interest expense 
Total other income 

2003 

Year ended December 31,  
2002 

2001 

  Amount 

% Sales 

  Amount 

% Sales 

  Amount 

% Sales 

 $    39,708 
         34,567
           7,028 
         81,303 

        48.9%
        42.5 
          8.6 
      100.0 

$    38,309 
        30,246 
          5,189 
        73,744 

        51.9% 
        41.0 
          7.1 
      100.0 

$   30,350 
           25,823 
             3,493 
           59,666 

          50.8%
          43.3   
            5.9 
        100.0 

         28,045 
         16,101 
           4,259 
         48,405 
         32,898 

         34.5 
         19.8 
           5.2 
         59.5 
         40.5 

        25,838 
        13,905 
          3,182 
        42,925 
        30,819 

         35.0 
         18.9 
           4.3 
         58.2 
         41.8 

           22,499 
           11,634 
             2,109 
           36,242 
           23,424 

           37.7 
           19.5 
             3.5 
           60.7 
           39.3 

           6,125 
         14,227 
         20,352 
         12,546 

           7.5 
         17.5 
         25.0 
         15.5 

          5,933 
        12,817 
        18,750 
        12,069 

           8.0 
         17.4 
         25.4 
         16.4 

             5,105 
             9,843 
           14,948 
             8,476 

             8.6 
           16.5 
           25.1 
           14.2 

              216 
              122 
                  -
              338 

           0.3 
           0.1 
           0.0 
           0.4 

             214 
             362 
             (24)
             552 

           0.3 
           0.5 
           0.0 
           0.8 

                126 
                154 
               (76)
                204 

             0.2 
             0.2 
            -0.1 
             0.3 

Income before taxes 

         12,884 

         15.9 

        12,621 

         17.2 

             8,680 

           14.5 

Income taxes 

           5,018

           6.2 

          1,971 

           2.7 

                    -

                -  

Net income 

 $       7,866 

          9.7%

$    10,650 

        14.5% 

 $      8,680 

          14.5%

2003 Compared to 2002 

Revenues. Total revenues increased by 10.2% or $7.6 million to $81.3 million for 2003 from 

$73.7 million for 2002. 

System sales revenues increased by 3.7% or $1.4 million to $39.7 million in 2003 from $38.3 
million in 2002. The increase in system sales revenues was attributable to an increase in the number of 
new customer installations and an increase in the purchase of additional products by existing customers. 
No costs relating to system sales were deferred under our completed contract method of accounting at 
December 31, 2003 or 2002 as all contracts were deemed to be substantially complete.   

26 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Our 3.7% growth rate in system sales is less than the 23.6% growth rate we achieved from 2001 

to 2002.  We experienced slowed growth in system sales revenues during 2003 because of adverse 
financial conditions affecting community hospitals, including a weak Medicare and Medicaid 
reimbursement environment, high salary costs due to a nationwide shortage of clinical professionals such 
as nurses and pharmacists, and lower than anticipated patient admissions.  Many hospitals delayed 
making significant information technology purchases due to lack of available capital.  Although we added 
a record 48 new hospital clients in 2003, most hospitals approved purchases for the minimum amount of 
software needed to begin the installation of an integrated system.  These smaller purchases caused the size 
of our average installation contract to decrease from approximately $650,000 in 2002 to approximately 
$500,000 in 2003. 

Support and maintenance revenues increased by 14.3% or $4.3 million to $34.6 million in 2003 

from $30.2 million in 2002.  The increase in support and maintenance revenues was attributable to an 
increase in recurring revenues as a result of a larger customer base.  We had 490 customers at December 
31, 2003, compared to 444 at December 31, 2002.  ASP services revenues increased by 21.4% or $0.4 
million and ISP services revenues increased by 20.8% or $0.1 million. 

Outsourcing revenues increased by 35.4% or $1.8 million to $7.0 million in 2003 from $5.2 

million in 2002. We experienced an increase in outsourcing revenues as a result of continued growth in 
customer demand for electronic billing and statement outsourcing services. Statement outsourcing 
revenues increased 17.5% and electronic billing revenues increased 36.4%.  We were providing business 
outsourcing services to four customers at December 31, 2003. 

Costs of Sales. Total costs of sales increased by 12.8% or $5.5 million to $48.4 million in 2003 
from $42.9 million in 2002. As a percentage of revenues, cost of sales increased to 59.5% for 2003 from 
58.2% for 2002. 

Cost of system sales increased by 8.5% or $2.2 million to $28.0 million for 2003 from $25.8 

million for 2002. This increase was caused primarily by an increase in travel expenses of $0.6 million as a 
result of a combination of factors including an increase in the sale of add-on clinical programs requiring 
larger installation teams and installations in geographic locations with higher travel costs.  Additionally, 
payroll related expenses increased $1.0 million as a result of increased average employee headcount 
needed to support increasing sales volume. Cost of equipment also increased by $0.2 million as a direct 
result of our increase in system sales. Cost of software increased by $0.4 million as compared to 2002 
because of a settlement payment from a software vendor in 2002 that caused the software costs that year 
to be unusually low.  The gross margin on system sales decreased to 29.4% for 2003 from 32.6% for 
2002.  

Cost of support and maintenance increased by 15.8% or $2.2 million to $16.1 million for 2003 

from $13.9 million for 2002. This increase was caused primarily by an increase in payroll related 
expenses of $1.9 million as a result of increased average employee headcount needed to support our 
increasing customer base. Also, telecommunication expenses increased $0.1 million due to increased 
utilization of our ISP services.  The gross margin on support and maintenance revenues decreased to 
53.4% for 2003 from 54.0% for 2002.  The decrease in the gross margin was primarily due to the addition 
of customer support personnel. 

Our costs associated with outsourcing services increased 33.8% or $1.1 million to $4.3 million in 

2003 from $3.2 million in 2002. Salary expense increased $0.5 million due to the full-year expense of 
additional employees hired during 2002 to support our business office outsourcing services. Postage costs 
increased $0.5 million as a result of a postal rate increase and an increase in transaction volumes of our 
statement outsourcing services. 

27 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Sales and Marketing Expenses.  Sales and marketing expenses increased 3.2% or $0.2 million to 

$6.1 million in 2003 from $5.9 million in 2002.  The increase was attributable to increased salary expense 
of $0.2 million that resulted from the addition of sales personnel. 

General and Administrative Expenses. General and administrative expenses increased by 11.0% 
or $1.4 million to $14.2 million for 2003 from $12.8 million for 2002.  The increase was due primarily to 
an increase in employee group health insurance of $0.5 million and salary increases of $0.3 million. 
Additional expense increases, which resulted from our continued growth, were $0.3 million for 
depreciation, $0.1 million for telecommunications, and $0.2 million for facilities rent. The increases were 
offset by a decrease of $0.6 million in bad debt expense. We have also experienced increased expenses of 
$0.3 million in professional fees, investor relations and directors’ fees.   

As a result of the foregoing factors, income before taxes increased by 2.1% or $0.3 million to 

$12.9 million for 2003 from $12.6 million for 2002.  This growth rate in income before taxes is less than 
the growth rate we achieved from 2001 to 2002, primarily because of the slower growth in system sales 
revenues described above. 

2002 Compared to 2001  

Revenues. Total revenues increased by 23.6% or $14.0 million to $73.7 million for 2002 from 

$59.7 million for 2001. 

System sales revenues increased by 26.2% or $7.9 million to $38.3 million in 2002 from $30.4 
million in 2001. The increase in system sales revenue was attributable to an increase in the number and 
size of new customer installations. No costs relating to system sales were deferred under our completed 
contract method of accounting at December 31, 2002 or 2001 as all contracts were deemed to be 
substantially complete.   

Support and maintenance revenues increased by 17.1% or $4.4 million to $30.2 million in 2002 

from $25.8 million in 2001.  The increase in support and maintenance revenues was attributable to an 
increase in recurring revenues as a result of a larger customer base, as well as an increase in ASP and ISP 
services volume. 

Outsourcing revenues increased by 48.6% or $1.7 million to $5.2 million in 2002 from $3.5 

million in 2001. We experienced an increase in outsourcing revenues as a result of continued growth in 
customer demand for electronic billing and statement outsourcing services. We initiated business office 
outsourcing services during the first quarter of 2002 and were providing services to four customers at 
December 31, 2002. 

Costs of Sales. Total costs of sales increased by 18.4% or $6.7 million to $42.9 million in 2002 

from $36.2 million in 2001. As a percentage of revenues, cost of sales decreased from 60.7% for 2001 to 
58.2% for 2002. 

Cost of system sales increased by 14.7% or $3.3 million to $25.8 million for 2002 from $22.5 

million for 2001. This increase was caused primarily by an increase in travel expenses of $0.8 million as a 
direct result of larger system installations requiring larger installation teams. Additionally, payroll related 
expenses increased $1.4 million as a result of increased employee headcount needed to support increasing 
sales volume. Cost of equipment also increased by $1.1 million as a direct result of our increase in system 
sales. The gross margin on system sales increased to 32.6% for 2002 from 25.9% for 2001. The increase 
in gross margin was due to an increase in the average size of systems installed in 2002 over 2001. 

28 

 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Cost of support and maintenance increased by 19.8% or $2.3 million to $13.9 million for 2002 

from $11.6 million for 2001. This increase was caused primarily by an increase in payroll related 
expenses of $2.0 million as a result of increased employee headcount needed to support our increasing 
customer base. Also, telecommunication expenses increased $0.3 million due to increased utilization of 
our ISP services.  The gross margin on support and maintenance revenues decreased to 54.0% for 2002 
from 54.9% for 2001.  The decrease in the gross margin was primarily due to the addition of customer 
support personnel necessary for the planned expansion of our customer base. 

Our costs associated with outsourcing services increased 52.3% or $1.1 million to $3.2 million in 

2002 from $2.1 million in 2001. Salary expense increased $0.5 million due to the hiring of additional 
employees to support our business office outsourcing services. Postage cost increased $0.5 million and 
cost of forms increased $0.1 million as a result of an increase in transaction volumes of our statement 
outsourcing services. 

Sales and Marketing Expenses.  Sales and marketing expenses increased 15.7% or $0.8 million to 

$5.9 million in 2002 from $5.1 million in 2001.  The increase was attributable to increased commission 
expense of $0.8 million that resulted from increased sales volumes. 

General and Administrative Expenses. General and administrative expenses increased by 30.2% 
or $3.0 million to $12.8 million for 2002 from $9.8 million for 2001.  The increase was due primarily to 
increases in employee related expenses of $1.1 million as a result of an increase in employees to 650 at 
December 31, 2002 from 548 at December 31, 2001. Additional expense increases, which resulted from 
our continued growth, were $0.2 million for depreciation, $0.2 million for telecommunications, $0.2 
million for facilities rent and $0.6 million related to bad debts. We have also experienced increased 
expenses of $0.7 million in professional fees, investor relations and directors’ fees, which resulted from 
becoming a public company.   

As a result of the foregoing factors, income before taxes increased by 44.8% or $3.9 million to 

$12.6 million for 2002 from $8.7 million for 2001. 

Liquidity and Capital Resources 

As of March 10, 2004, we had $9.3 million in cash and cash equivalents.  This cash reserve plus 

cash generated from our normal operating activities should be adequate to fund our business for the 
foreseeable future. Our principal source of liquidity has been cash provided by operating activities. Cash 
provided by operating activities has been used primarily to fund the growth in our business and, prior to 
our IPO, to pay S corporation distributions to our stockholders. We paid cash distributions to our pre-IPO 
stockholders in the aggregate amounts of $0.3 million, $16.9 million and $6.6 million in 2003, 2002 and 
2001, respectively. Because of our strong cash position, our board of directors decided to begin paying a 
quarterly dividend in 2003, and we declared and paid dividends in the aggregate amount of $2.7 million.  
We believe that paying dividends is an effective way of providing an investment return to our 
stockholders and a beneficial use of our cash. 

Net cash provided by operating activities totaled $8.0 million, $7.0 million and $9.0 million for 
2003, 2002 and 2001, respectively.  The decrease in cash provided by operating activities from 2001 to 
2002 was primarily related to an increase in accounts receivable.  In 2003, we experienced significant 
improvement in our cash collections, which produced a meaningful increase in our cash from operating 
activities.  Upon the completion of our IPO, we converted from an S corporation to a C corporation for 
tax purposes. As a result, some of our cash provided by our operating activities is now required to pay 
taxes on our income. 

29 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net cash used in investing activities totaled $2.0 million, $1.9 million and $1.3 million for 2003, 

2002 and 2001, respectively.  In each of those years we used cash for the purchase of property and 
equipment.  

Net cash used in financing activities totaled $2.9 million, $0.7 million and $6.7 million for 2003, 

2002 and 2001, respectively.  During 2003, we declared and paid dividends in the aggregate amount of 
$2.7 million.  We also made a final cash distribution to our pre-IPO stockholders in the amount of $0.3 
million for previously taxed S corporation income.  During 2002, we received $16.9 million as net 
proceeds from our IPO.  Prior to the IPO, we made cash distributions to our stockholders in the amount of 
$2.6 million.  From the IPO proceeds, we made additional cash distributions to our pre-IPO stockholders 
in the amount of $14.3 million for previously taxed S corporation income.  We also retired outstanding 
long-term debt in the amount of $0.7 million.  During 2001, we used cash primarily to pay cash 
distributions to our stockholders.   

Our days sales outstanding for the years 2003, 2002 and 2001 were 50.0, 56.8 and 41.7 

respectively. 

We currently do not have a bank line of credit or other credit facility in place. Because we have 
no debt, we will not be subject to contractual restrictions or other influences on our operations, such as 
payment demands and restrictions on the use of operating funds that are typically associated with debt. If 
we borrow money in the future, we will likely be subject to operating and financial covenants that could 
limit our ability to operate as profitably as we have in the past. Defaults under applicable loan agreements 
could result in the demand by lenders for immediate payment of substantial funds and substantial 
restrictions on expenditures, among other things. 

Related Party Transactions 

We lease the majority of our corporate headquarters campus from CP Investments, Inc., an 

Alabama corporation, the stockholders of which are John Morrissey, John Heyer, Bob O'Donnell, Elissa 
Stillings, Kevin P. Wilkins, Tabitha M. Wilkins Olzinski, Ellen M. Harvey, Michael K. Muscat, Jr. and 
Susan M. Slaton. All of these individuals are either stockholders of CPSI, or, in the case of Ms. Stillings, 
the spouse of a stockholder.  In 2003, we paid total lease payments in the amount of $1,284,978 to CP 
Investments, Inc. Under these lease agreements, we make annual lease payments in the amount of 
$1,325,275, subject to adjustment as set forth in the agreements. The annual rent payable under these 
leases has been determined by an independent, third-party appraisal firm. The parties may agree, from 
time to time, to make adjustments in the annual rent payable under these leases based on subsequent third-
party appraisals.  

We lease the remainder of our headquarters facilities, which is comprised of one building that 

houses our dedicated research and development staff, from DJK, LLC, a limited liability company owned 
by Dennis Wilkins.  In 2003, we paid total lease payments in the amount of $39,747 to DJK, LLC.   The 
annual rent payable under this lease has been determined by an independent, third-party appraisal firm.  

30 

 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
Contractual Obligations 

Our related party real estate leases are our only material contractual obligations requiring 
recurring payments in the future. Our payments under these leases subsequent to December 31, 2003 will 
be as follows: 

Contractual Obligations 

Total 

Payments due by period 

Less than 
1 year 

1-3 years 

3-5 years 

More than 
5 years 

Operating Lease 
Obligations 

$11,431,525

$1,365,275

$2,730,550

$2,730,550 

$4,605,150

Off-Balance Sheet Arrangements 

We are not currently a party to any material “off-balance sheet arrangement” as defined in Item 303 

of Regulation S-K. 

Critical Accounting Policies    

General. Our discussion and analysis of our financial condition and results of operations are 
based on our financial statements, which have been prepared in accordance with generally accepted 
accounting principles. We are required to make some estimates and judgments that affect the preparation 
of these financial statements. We base our estimates on historical experience and on various other 
assumptions that we believe to be reasonable under the circumstances, but actual results may differ from 
these estimates under different assumptions or conditions. 

Revenue Recognition.  We recognize revenue in accordance with SEC Staff Accounting Bulletin 
No. 101 (SAB 101), Revenue Recognition in Financial Statements, as amended by SAB 101A and 101B 
and the American Institute of Certified Public Accountants Statement of Position (SOP) 97-2, Software 
Revenue Recognition. SAB 101 and SOP 97-2 require that four basic criteria must be met before 
revenues can be recognized: (1) persuasive evidence that an arrangement exists; (2) delivery has occurred 
or services have been rendered; (3) the fee is fixed and determinable; and (4) collectibility is reasonably 
assured. Determination of criteria (3) and (4) are based on our judgment regarding the fixed nature of the 
fee charged for services rendered and products delivered and the collectibility of those fees. Should 
changes in conditions cause us to determine these criteria are not met for certain future transactions, 
revenues recognized for any reporting period could be adversely affected.  

Backlog 

Backlog consists of revenues we reasonably expect to recognize over the next twelve months 

under existing contracts. The revenues to be recognized may relate to a combination of one-time fees for 
system sales, and recurring fees for support, outsourcing, ASP and ISP services. As of December 31, 
2003, we had a twelve-month backlog of approximately $15.8 million in connection with non-recurring 
system purchases and approximately $44.9 million in connection with recurring payments under support, 
outsourcing, ASP and ISP contracts.       

Quantitative and Qualitative Disclosures about Market and Interest Rate Risk  

We reduce the sensitivity of our results of operations to market risks related to changes in interest 
rates by maintaining an investment portfolio comprised solely of highly rated, short-term investments. We 
do not hold or issue derivative, derivative commodity instruments or other financial instruments for 

31 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
trading purposes. We are not exposed to currency exchange fluctuations, as we do not sell our products 
internationally, and we currently have no exposure to equity price risks.  

Recent Accounting Pronouncements  

In June 2001, the FASB issued SFAS No. 143, Accounting for Asset Retirement Obligations.  

SFAS No. 143 addresses financial accounting and reporting for obligations associated with the retirement 
of tangible long-lived assets and the associated asset retirement costs.  It applies to legal obligations 
associated with the retirement of long-lived assets that result from the acquisition, construction, 
development and/or the normal operation of a long-lived asset, except for certain obligations of lessees.  
The adoption of this standard in 2003 did not have any effect on the Company’s financial position, results 
of operations or cash flows. 

In August 2001, the FASB issued SFAS No. 144, Accounting for the Impairment or Disposal of 

Long-Lived Assets.  SFAS No. 144 addresses financial accounting and reporting for the impairment or 
disposal of long-lived assets.  The adoption of this standard in 2002 did not have any effect on the 
Company’s financial position, results of operations or cash flows. 

In July 2002, the FASB issued SFAS No. 146, Accounting for Costs Associated with Exit or 

Disposal Activities. SFAS No. 146 addresses significant issues regarding the recognition, measurement 
and reporting of costs that are associated with exit and disposal activities, including restructuring 
activities that are currently accounted for pursuant to the guidance set forth in EITF No. 94-3, Liability 
Recognition for Certain Employee Termination Benefits and Other Costs to Exit an Activity. SFAS No. 
146 revises the accounting for certain lease termination costs and employee termination benefits, which 
are generally recognized in connection with restructuring activities. Adoption of this standard in 2003 did 
not have any effect on the Company’s financial position, results of operations or cash flows. 

On December 31, 2002, the FASB issued SFAS No. 148, Accounting for Stock-Based 

Compensation—Transition and Disclosure. SFAS No. 148 amends SFAS No. 123, Accounting for Stock-
Based Compensation, to provide alternative methods of transition to SFAS No. 123’s fair value method of 
accounting for stock-based employee compensation. SFAS No. 148 also amends the disclosure provisions 
of SFAS No. 123 and APB Opinion No. 28, Interim Financial Reporting, to require disclosure in the 
summary of significant accounting policies of the effect’s of an entity’s accounting policy with respect to 
stock-based compensation. While the Statement does not amend SFAS No. 123 to require companies to 
account for employee stock options using the fair value method, the disclosure provisions of SFAS No. 
148 are applicable to all companies with stock-based employee compensation, regardless of whether they 
account for that compensation using the fair value method of SFAS No. 123 or the intrinsic value method 
of Opinion 25.  The Company adopted the disclosure requirement of this standard in 2002. 

In January 2003, the FASB issued Interpretation 46 (FIN46), Consolidation of Variable Interest 

Entities. In general, a variable interest entity is a corporation, partnership, trust, or any other legal 
structure used for business purposes that either (a) does not have equity investors with voting rights or (b) 
has equity investors that do not provide sufficient financial resources for the entity to support its 
activities. FIN 46 requires a variable interest entity to be consolidated by a company if that company is 
subject to a majority of the risk of loss from the variable interest entity's activities or entitled to receive a 
majority of the entity's residual returns or both. The consolidation requirements of FIN 46 apply 
immediately to variable interest entities created after January 31, 2003. The consolidation requirements 
apply to transactions entered into prior to February 1, 2003 in the first fiscal year or interim period 
beginning after June 15, 2003. Certain of the disclosure requirements apply in all financial statements 

32 

 
 
 
 
 
 
 
 
 
 
issued after January 31, 2003, regardless of when the variable interest entity was established. The 
adoption of FIN 46 on July 1, 2003 did not have an impact on our financial statements.  

In December 2003, the FASB issued Interpretation 46R (FIN 46R), a revision to FIN 46, 

Consolidation of Variable Interest Entities. FIN 46R clarifies some of the provisions of FIN 46 and 
exempts certain entities from its requirements. FIN 46R is effective at the end of the first interim period 
ending after March 15, 2004. Entities that have adopted FIN 46 prior to this effective date can continue to 
apply the provisions of FIN 46 until the effective date of FIN 46R. As noted above, CPSI adopted FIN 46 
on July 1, 2003 and it did not have an impact on our financial statements. The early adoption of FIN 46R 
did not have an impact on our financial statements. 

In April 2003, the FASB issued SFAS 149, Amendment of Statement 133 on Derivative 
Instruments and Hedging Activities, which amends and clarifies accounting for derivative instruments, 
including certain derivative instruments embedded in other contracts, and for hedging activities under 
SFAS 133. The statement is effective (with certain exceptions) for contracts entered into or modified after 
June 30, 2003. This statement will not have an impact on our financial statements.  

In May 2003, the FASB issued SFAS 150, Accounting for Certain Financial Instruments with 

Characteristics of both Liabilities and Equity. The statement establishes standards for how an issuer 
classifies and measures certain financial instruments with characteristics of both liabilities and equity. It 
requires that an issuer classify a financial instrument that is within its scope as a liability (or an asset in 
some circumstances). It is effective for financial instruments entered into or modified after May 31, 2003, 
and otherwise is effective at the beginning of the first interim period beginning after June 15, 2003. This 
statement will not have an impact on our financial statements. 

RISK FACTORS 

Market factors may cause a decline in spending for information technology and services by our 
current and prospective customers which may result in less demand for our products, lower prices 
and, consequently, lower revenues and a lower revenue growth rate. 

The purchase of our information system involves a significant financial commitment by our 
customers. At the same time, the healthcare industry faces significant financial pressures that could 
adversely affect overall spending on healthcare information technology and services. For example, the 
Balanced Budget Act of 1997 has significantly reduced Medicare reimbursements to hospitals, leaving 
them less money to invest in infrastructure. Moreover, a general economic decline could cause hospitals 
to reduce or eliminate information technology related spending. To the extent spending for healthcare 
information technology and services declines or increases slower than we anticipate, demand for our 
products and services, as well as the prices we charge, could be adversely affected. Accordingly, we 
cannot assure you that we will be able to increase or maintain our revenues or our growth rate. 

There are a limited number of hospitals in our target market. Continued consolidation in the 
healthcare industry could result in the loss of existing customers, a reduction in our potential 
customer base and downward pressure on our products' prices. 

There are a finite number of small and midsize hospitals with 300 or fewer acute care beds. 
Saturation of this market with our products or our competitors' products could eventually limit our 
revenues and growth. Furthermore, many healthcare providers have consolidated to create larger 
healthcare delivery enterprises with greater market power. If this consolidation continues, we could lose 
existing customers and could experience a decrease in the number of potential purchasers of our products 
and services. The loss of existing and potential customers due to industry consolidation could cause our 

33 

 
 
 
 
   
   
   
 
 
 
 
 
 
revenue growth rate to decline. In addition, larger, consolidated enterprises could have greater bargaining 
power, which may lead to downward pressure on the prices for our products and services. 

We may experience fluctuations in quarterly financial performance that cause us to fail to meet 
revenues or earnings expectations. Failure to meet these expectations could adversely impact our 
stock price. 

There is no assurance that consistent quarterly growth in our business will continue. Our quarterly 
revenues may fluctuate and may be difficult to forecast for a variety of reasons. For example, prospective 
customers often take significant time evaluating our system and related services before making a purchase 
decision. Moreover, a prospective customer who has placed an order for our system could decide to 
cancel that order or postpone installation of the ordered system. If a prospective customer delays or 
cancels a scheduled system installation during any quarter, we may not be able to schedule a substitute 
system installation during that quarter. The amount of revenues that would have been generated from that 
installation will be postponed or lost. The possibility of delays or cancellations of scheduled system 
installations could cause our quarterly revenues to fluctuate. 

The following factors may also affect demand for our products and services and cause our 

quarterly revenues to fluctuate: 

• 
• 

• 
• 

changes in customer budgets and purchasing priorities; 
market acceptance of new products, product enhancements and services from us 
and our competitors; 
product and price competition; and 
delay of revenue recognition to future quarters due to an increase in the sale of 
our remote access ASP services. 

Variations in our quarterly revenues may adversely affect our operating results. In each fiscal 

quarter, our expense levels, operating costs and hiring plans are based on projections of future revenues 
and are relatively fixed. If our actual revenues fall below expectations, our earnings will also likely fail to 
meet expectations. If we fail to meet the revenue or earnings expectations of securities analysts and 
investors, then the price of our common stock will likely decrease. 

Competition with companies that have greater financial, technical and marketing resources than 
we have could result in loss of customers and/or a lowering of prices for our products, causing a 
decrease in our revenues and/or market share.  

Our principal competitors are Meditech and HMS.  Meditech and HMS compete with us directly 
in our target market of small and midsize hospitals. These companies offer products and services that are 
comparable to our system and are designed to address the needs of community hospitals.  

Our secondary competitors include McKesson Corporation, Quadramed Corp., Cerner 
Corporation, and Siemens Corporation. These companies are significantly larger than we are, and they 
typically sell their products and services to larger hospitals outside of our target market. However, they 
sometimes compete directly with us. We also face competition from providers of practice management 
systems, general decision support and database systems and other segment-specific applications, as well 
as from healthcare technology consultants. Any of these companies as well as other technology or 
healthcare companies could decide at any time to specifically target hospitals within our target market.  

A number of existing and potential competitors are more established than we are and have greater 
name recognition and financial, technical and marketing resources. Products of our competitors may have 

34 

 
 
 
 
 
 
 
 
        
         
 
 
 
 
 
 
 
 
better performance, lower prices and broader market acceptance than our products. We expect increased 
competition that could cause us to lose customers, lower our prices to remain competitive and experience 
lower revenues, revenue growth and profit margins.  

Our failure to develop new products or enhance current products in response to market demands 
could adversely impact our competitive position and require substantial capital resources to 
correct. 

The needs of hospitals in our target market are subject to rapid change due to government 
regulation, trends in clinical care practices and technological advancements. As a result of these changes, 
our products may quickly become obsolete or less competitive. New product introductions and 
enhancements by our competitors that more effectively or timely respond to changing industry needs may 
weaken our competitive position. 

We continually redesign and enhance our products to incorporate new technologies and adapt our 

products to ever-changing hardware and software platforms. Often we face difficult choices regarding 
which new technologies to adopt. If we fail to anticipate or respond adequately to technological 
advancements, or experience significant delays in product development or introduction, our competitive 
position could be negatively affected. Moreover, our failure to offer products acceptable to our target 
market could require us to make significant capital investments and incur higher operating costs to 
redesign our products, which could negatively affect our financial condition and operating results.  

Potential regulation of our products as medical devices by the U.S. Food and Drug Administration 
could increase our costs, delay the introduction of new products and slow our revenue growth. 

The U.S. Food and Drug Administration, or the "FDA," is likely to become more active in regulating 
the use of computer software for clinical purposes. The FDA has increasingly regulated computer products 
and computer-assisted products as medical devices under the federal Food, Drug and Cosmetic Act. If the 
FDA regulates any of our products as medical devices, we would likely be required to, among other things: 

• 

• 

• 

seek FDA clearance by demonstrating that our product is substantially equivalent 
to a device already legally marketed, or obtain FDA approval by establishing the 
safety and effectiveness of our product; 

comply with rigorous regulations governing pre-clinical and clinical testing, 
manufacture, distribution, labeling and promotion of  medical devices; and 

comply with the Food, Drug and Cosmetic Act's general controls, including 
establishment registration, device listing, compliance  with good manufacturing 
practices and reporting of specified device malfunctions and other adverse device 
events. 

We anticipate that some of our products currently in development will be subject to FDA 

regulation. If any of our products fail to comply with FDA requirements, we could face FDA refusal to 
grant pre-market clearance or approval of products; withdrawal of existing clearances and approvals; 
fines, injunctions or civil penalties; recalls or product corrections; production suspensions; and criminal 
prosecution. FDA regulation of our products could increase our operating costs, delay or prevent the 
marketing of new or existing products and adversely affect our revenue growth. 

35 

 
 
 
 
 
 
 
 
 
 
 
        
 
 
         
 
 
Governmental regulations relating to patient confidentiality and other matters could increase our 
costs. 

State and federal laws regulate the confidentiality of patient records and the circumstances under 

which those records may be released. These regulations may require the users of such information to 
implement security measures. Regulations governing electronic health data transmissions are also 
evolving rapidly, and they are often unclear and difficult to apply. 

The Health Insurance Portability and Accountability Act of 1996, or "HIPAA," requires, among 

other things, the Secretary of Health and Human Services, or "HHS," to adopt national standards to 
ensure the integrity and confidentiality of health information.  HHS’s health data privacy regulations 
restrict the use and disclosure of personally identifiable health information without the prior informed 
consent of the patient. In addition, HHS has also issued final regulations establishing national standards 
for some healthcare-related electronic transactions and uniform code sets to be used in those transactions. 
Although these regulations were to be effective in October 2003, CMS is currently allowing providers and 
payers to continue utilizing non-compliant transaction code sets.  The length of this grace period has not 
yet been determined.  In February 2003, HHS issued final rules with respect to information security that 
would require healthcare providers to implement organizational practices to protect the security of 
electronically maintained or transmitted health-related information, such as the use of electronic 
signatures and single sign-on access to information. Customers must be in compliance with these new 
regulations by April 2005. HHS has also provided a final rule for employer identifiers; however no other 
rules, proposed or final, have yet been issued with respect to unique health identifiers for providers or 
patients.  We cannot predict the potential impact of proposed rules and rules that have not yet been 
proposed. In addition to HIPAA, other federal and/or state privacy legislation may be enacted at any time.  

In our support agreements with our customers, we agree to update our software applications to 
comply with applicable federal and state laws. While we believe we have developed products that will 
comply with current HIPAA and other regulatory requirements, new laws, regulations and interpretations 
could force us to further redesign our products. Any such product redesign could consume significant 
capital, research and development and other resources, which could significantly increase our operating 
costs. 

Our products assist clinical decision-making and related care by capturing, maintaining and 
reporting relevant patient data. If our products fail to provide accurate and timely information, our 
customers could assert claims against us that could result in substantial cost to us, harm our 
reputation in the industry and cause demand for our products to decline. 

We provide products that assist clinical decision-making and related care by capturing, 
maintaining and reporting relevant patient data. Our products could fail or produce inaccurate results due 
to a variety of reasons, including mechanical error, product flaws, faulty installation and/or human error 
during the initial data conversion. If our products fail to provide accurate and timely information, 
customers and/or patients could sue us to hold us responsible for losses they incur from these errors. 
These lawsuits, regardless of merit or outcome, could result in substantial cost to us, divert management's 
attention from operations and decrease market acceptance of our products. We attempt to limit by contract 
our liability for damages arising from negligence, errors or mistakes. Despite this precaution, such 
contract provisions may not be enforceable or may not otherwise protect us from liability for damages. 
We maintain general liability insurance coverage, including coverage for errors or omissions. However, 
this coverage may not be sufficient to cover one or more large claims against us or otherwise continue to 
be available on terms acceptable to us. In addition, the insurer could disclaim coverage as to any future 
claim. 

36 

 
 
 
 
 
 
 
 
 
 
 
 
 
Breaches of security in our system could result in customer claims against us and harm to our 
reputation causing us to incur expenses and/or lose customers.  

We have included security features in our systems that are intended to protect the privacy and 

integrity of patient data. Despite the existence of these security features, our system may experience 
break-ins and similar disruptive problems that could jeopardize the security of information stored in and 
transmitted through the computer networks of our customers. Because of the sensitivity of medical 
information, customers could sue us for breaches of security involving our system. Also, actual or 
perceived security breaches in our system could harm the market perception of our products which could 
cause us to lose existing and prospective customers. 

New products that we introduce or enhancements to our existing products may contain undetected 
errors or problems that could affect customer satisfaction and cause a decrease in revenues. 

Highly complex software products such as ours sometimes contain undetected errors or failures 

when first introduced or when updates and new versions are released. Tests of our products may not 
detect bugs or errors because it is difficult to simulate our customers' wide variety of computing 
environments. Despite extensive testing, from time to time we have discovered defects or errors in our 
products. Defects or errors discovered in our products could cause delays in product introductions and 
shipments, result in increased costs and diversion of development resources, require design modifications, 
decrease market acceptance or customer satisfaction with our products, cause a loss of revenue, result in 
legal actions by our customers and cause increased insurance costs. 

Our facilities are located in an area vulnerable to hurricanes and tropical storms, and the 
occurrence of a severe hurricane, similar storm or other natural disaster could cause damage to our 
facilities and equipment, which could require us to cease or limit our operations. 

All of our facilities and virtually all of our employees are situated on one campus in Mobile, 

Alabama, which is located on the coast of the Gulf of Mexico. Our facilities are vulnerable to significant 
damage or destruction from hurricanes and tropical storms. We are also vulnerable to damage from other 
types of disasters, including tornadoes, fires, floods and similar events. If any disaster were to occur, our 
ability to conduct business at our facilities could be seriously impaired or completely destroyed. This 
would have adverse consequences for our customers who depend on us for system support or outsourcing 
services. Also, the servers of customers who use our remote access services could be damaged or 
destroyed in any such disaster. This would have potentially devastating consequences to those customers. 
Although we have an emergency recovery plan, there can be no assurance that this plan will effectively 
prevent the interruption of our business due to a natural disaster. Furthermore, the insurance we maintain 
may not be adequate to cover our losses resulting from any natural disaster or other business interruption. 

Interruptions in our power supply and/or telecommunications capabilities could disrupt our 
operations, cause us to lose revenues and/or increase our expenses.  

We currently have backup generators to be used as alternative sources of power in the event of a 

loss of power to our facilities. If these generators were to fail during any power outage, we would be 
temporarily unable to continue operations at our facilities. This would have adverse consequences for our 
customers who depend on us for system support and outsourcing services. Any such interruption in 
operations at our facilities could damage our reputation, harm our ability to retain existing customers and 
obtain new customers, and could result in lost revenue and increased insurance and other operating costs.  

We also have customers for whom we store and maintain computer servers containing critical 

patient and administrative data. Those customers access this data remotely through telecommunications 

37 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
lines. If our power generators fail during any power outage or if our telecommunications lines are severed 
or impaired for any reason, those customers would be unable to access their mission critical data causing 
an interruption in their operations. In such event our remote access customers and/or their patients could 
seek to hold us responsible for any losses. We would also potentially lose those customers, and our 
reputation could be harmed. 

If we are unable to attract and retain qualified customer service and support personnel our 
business and operating results will suffer. 

Our customer service and support is a key component of our business. Most of our hospital 

customers have small information technology staffs, and they depend on us to service and support their 
systems. Future difficulty in attracting, training and retaining capable customer service and support 
personnel could cause a decrease in the overall quality of our customer service and support. That decrease 
would have a negative effect on customer satisfaction which could cause us to lose existing customers and 
could have an adverse effect on our new customer sales. The loss of customers due to inadequate 
customer service and support would negatively impact our ability to continue to grow our business.  

We do not have employment or non-competition agreements with our key personnel, and their 
departure could harm our future success. 

Our future success depends to a significant extent on the leadership and performance of our chief 

executive officer, chief operating officer and other executive officers. We do not have employment or 
non-competition agreements with any of our executive officers. Therefore, they may terminate their 
employment with us at any time and may compete against us. The loss of the services of any of our 
executive officers could have a material adverse effect on our business, financial condition and results of 
operations. 

We have limited protection of our intellectual property and, if we fail to adequately protect our 
intellectual property, we may not be able to compete effectively. 

We consider some aspects of our internal operations, products and documentation to be 
proprietary. To some extent we have relied on a combination of confidentiality provisions in our customer 
agreements, copyright, trademark and trade secret laws and other measures to protect our intellectual 
property. To date, however, we have not filed any patent applications to protect our proprietary software 
products. In addition, existing copyright laws afford only limited protection. Although we attempt to 
control access to our intellectual property, unauthorized persons may attempt to copy or otherwise use our 
intellectual property. Monitoring unauthorized use of our intellectual property is difficult, and the steps 
we have taken may not prevent unauthorized use. If our competitors gain access to our intellectual 
property, our competitive position in the industry could be damaged. An inability to compete effectively 
could cause us to lose existing and potential customers and experience lower revenues, revenue growth 
and profit margins. 

In the event our products infringe on the intellectual property rights of third-parties, our business 
may suffer if we are sued for infringement or if we cannot obtain licenses to these rights on 
commercially acceptable terms.  

Others may sue us alleging infringement of their intellectual property rights. Many participants in 
the technology industry have an increasing number of patents and patent applications and have frequently 
demonstrated a readiness to take legal action based on allegations of patent and other intellectual property 
infringement. Further, as the number and functionality of our products increase, we believe we may 
become increasingly subject to the risk of infringement claims. If infringement claims are brought against 

38 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
us, these assertions could distract management. We may have to spend a significant amount of money and 
time to defend or settle those claims. If we were found to infringe on the intellectual property rights of 
others, we could be forced to pay significant license fees or damages for infringement. If we were unable 
to obtain licenses to these rights on commercially acceptable terms, we would be required to discontinue 
the sale of our products that contain the infringing technology. Our customers would also be required to 
discontinue the use of those products. We are unable to insure against this risk on an economically 
feasible basis. Even if we were to prevail in an infringement lawsuit, the accompanying publicity could 
adversely impact the demand for our system. Under some circumstances, we agree to indemnify our 
customers for some types of infringement claims that may arise from the use of our products. 

ITEM 7A. 

QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET 
RISK 

The information required by this item is contained in Item 7 herein under the heading 

"Quantitative and Qualitative Disclosures about Market and Interest Rate Risk." 

ITEM 8. 

FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA 

Index to Financial Statements:  

Financial Statements:  

Report of Ernst & Young LLP, Independent Auditors 

Balance Sheets – December 31, 2003 and 2002 

Statements of Income – Years ended December 31, 2003, 2002 and 2001 

Statements of Stockholders' Equity – Years ended December 31, 2003, 2002 and 
2001 

Statements of Cash Flows – Years ended December 31, 2003, 2002 and 2001 

Notes to Financial Statements 

Financial Statement Schedules:   

Schedule II – Valuation of Qualifying Accounts for each of the three years in the 
period ended December 31, 2003 

All other schedules to the financial statements required by Article 9 of 
Regulation S-X are inapplicable and therefore have been omitted. 

39 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
REPORT OF ERNST & YOUNG LLP, INDEPENDENT AUDITORS 

The Board of Directors 
Computer Programs and Systems, Inc. 

We have audited the accompanying balance sheets of Computer Programs and Systems, Inc. as of 
December 31, 2003 and 2002, and the related statements of income, stockholders’ equity and cash flows 
for each of the three years in the period ended December 31, 2003.  Our audits also included the financial 
statement schedule listed in the index at Item 8.  These financial statements and schedule are the 
responsibility of the Company’s management.  Our responsibility is to express an opinion on these 
financial statements and schedule based on our audits. 

We conducted our audits in accordance with auditing standards generally accepted in the United States. 
Those standards require that we plan and perform the audit to obtain reasonable assurance about whether 
the financial statements are free of material misstatement.  An audit includes examining, on a test basis, 
evidence supporting the amounts and disclosures in the financial statements.  An audit also includes 
assessing the accounting principles used and significant estimates made by management, as well as 
evaluating the overall financial statement presentation.  We believe that our audits provide a reasonable 
basis for our opinion. 

In our opinion, the financial statements referred to above present fairly, in all material respects, the 
financial position of Computer Programs and Systems, Inc. at December 31, 2003 and 2002, and the 
results of its operations and its cash flows for each of the three years in the period ended December 31, 
2003, in conformity with accounting principles generally accepted in the United States.  Also, in our 
opinion, the related financial statement schedule, when considered in relation to the financial statements 
taken as a whole, presents fairly in all material respects the information set forth therein. 

/s/ Ernst & Young LLP 

February 3, 2004 
Birmingham, Alabama 

40 

 
 
 
 
 
 
 
 
 
COMPUTER PROGRAMS AND SYSTEMS, INC. 

Balance Sheets 

Assets 

 Current assets: 

 Cash and cash equivalents 
 Accounts receivable, net of allowance for doubtful accounts 
 of $904,000 and $768,000, respectively 
 Financing receivables, current portion 
 Inventories 
 Deferred tax assets 
 Prepaid income taxes 
 Prepaid expenses 

Total current assets 

 Property and equipment 

 Land 
 Maintenance equipment 
 Computer equipment 
 Office furniture and equipment 
 Automobiles 

 Less accumulated depreciation 

Net property and equipment 
 Financing receivables 

Total assets 

Liabilities and Stockholders' Equity 

 Current liabilities: 

 Accounts payable 
 Deferred revenue 
 Sales, income and use taxes payable 
 Accrued vacation 
 Other accrued liabilities 
 Income taxes payable 

Total current liabilities 

 Stockholders' equity: 

 Common stock, $0.001 par value; 30,000,000 shares authorized; 
 10,489,849 and 10,488,000 shares issued and outstanding 
 Additional paid-in capital 
 Deferred compensation 
 Retained earnings 

Total stockholders' equity 

Total liabilities and stockholders' equity 

See accompanying notes. 

41 

December 31, 
2003 

  December 31, 
2002 

$       9,472,743 

   $       6,352,452 

       11,916,414 
         1,112,773 
         1,102,061 
            973,173 
            120,025 
            364,384 

          12,598,511 
            1,341,047 
            1,615,312 
            1,006,470 
                       -
               327,533 

        25,061,573 

          23,241,325 

            936,026 
         3,172,303 
         4,320,011 
         1,391,110 
              89,934 
         9,909,384 
        (4,561,080) 

               936,026 
            2,679,766 
            3,486,030 
            1,023,771 
                 89,934 
            8,215,527 
          (3,388,704)

         5,348,304 
            793,870 

            4,826,823 
               840,603 

$     31,203,747 

   $     28,908,751 

$       1,126,334 
         1,633,887 
              38,697 
          1,561,577 
         1,091,279 
                     - 

   $       2,093,812 
            2,347,816 
            1,258,553 
            1,317,247 
            1,218,741 
               193,546 

         5,451,774 

            8,429,715

              10,490 
        17,289,910 
           (174,385) 
         8,625,958 

                 10,488 
          17,259,403 
             (225,423)
            3,434,568 

       25,751,973 

          20,479,036 

$     31,203,747 

   $     28,908,751 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
COMPUTER PROGRAMS AND SYSTEMS, INC. 

Statements of Income 

Sales revenues: 
 System sales 
 Support and maintenance 
 Outsourcing 
Total sales revenues 

Costs of sales: 

 System sales 
 Support and maintenance 
 Outsourcing 
Total costs of sales 
Gross profit 

Operating expenses: 

 Sales and marketing 
 General and administrative 

Total operating expenses 
Operating income 

Other income (expense): 

 Interest income 
 Miscellaneous income 
 Interest expense 
Total other income 

2003 

Year ended December 31, 
2002 

2001 

 $     39,707,684 
       34,567,017 
         7,028,159 
       81,302,860 

$     38,309,227 
       30,246,030 
         5,188,963 
       73,744,220 

   $     30,350,201 
          25,822,575 
            3,493,629 
          59,666,405 

       28,045,002 
       16,100,525 
         4,258,778 
       48,404,305 
       32,898,555 

       25,837,901 
       13,905,072 
         3,182,430 
       42,925,403 
       30,818,817 

          22,498,667 
          11,634,448 
            2,108,672 
          36,241,787 
          23,424,618 

         6,125,437 
       14,227,439 
       20,352,876 
       12,545,679 

         5,933,472 
       12,816,785 
       18,750,257 
       12,068,560 

            5,104,906 
            9,843,543 
          14,948,449 
            8,476,169 

            216,001 
            121,797 
                       -
            337,798 

            214,044 
            361,682 
             (23,677) 
            552,049 

               125,881 
               153,892 
               (75,742)
               204,031 

Income before taxes 

       12,883,477 

       12,620,609 

            8,680,200 

Income taxes 

Net income 

         5,017,647 

         1,970,816 

                           -

$       7,865,830 

$     10,649,793 

   $       8,680,200 

Net income per share - basic 

$                0.75 

$                1.06 

   $                0.93 

Net income per share - diluted 

$                0.75 

$                1.06 

   $                0.93 

Weighted average shares outstanding 

 Basic 
 Diluted 

Unaudited pro forma income data: 
Historical income before provision for income taxes 
Pro forma income taxes 
Pro forma net income 

Pro forma net income per share – basic 

Pro forma net income per share – diluted 

See accompanying notes. 

42 

       10,488,406 
10,536,929 

       10,024,438 
10,061,765 

            9,288,000 
9,288,000 

$     12,620,609 
         4,576,654 
$       8,043,955 

   $       8,680,200 
            3,231,501 
   $       5,448,699 

$                0.80 

   $                0.59 

$                0.80 

   $                0.59 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
COMPUTER PROGRAMS AND SYSTEMS, INC. 

Statements of Stockholders’ Equity 

Common  
Shares 

 Common 
Stock 

Additional  
Paid-in  
Capital 

 Deferred  
Compensation 

 Retained  
Earnings 

Total 
Stockholders' 
Equity 

Balance at December 31, 2000 

       9,288,000  $     9,288  $      109,811   $                  -   $  7,837,083  $   7,956,182 

Net income 
Distributions to S corporation 
shareholders 

                     -                -                      -
                     -                -                      -

                     -       8,680,200 
     8,680,200 
                     -     (6,600,000)     (6,600,000)

Balance at December 31, 2001 

       9,288,000         9,288          109,811                       -       9,917,283 

   10,036,382 

Net income 
Issuance of common stock 
Deferred compensation 
Amortization of deferred compensation 
Distributions to S corporation 
shareholders 

   10,649,793 
                     -     10,649,793 
                     -                -                      -
   16,895,596 
                   -
       1,200,000         1,200     16,894,396                       - 
                     -
                   -
        255,196         (255,196) 
                     -                -
          29,773 
                     -                -                      -
          29,773 
                   -
                     -   (17,132,508)   (17,132,508)
                     -                -                      -

Balance at December 31, 2002 

     10,488,000       10,488     17,259,403         (225,423)       3,434,568 

   20,479,036 

Net income 
Issuance of common stock 
Dividends 
Amortization of deferred compensation 

                     -                -                      -
              1,849                2             30,507                       - 
                     -                -                      -
                     -                -                      -

     7,865,830 
                     -       7,865,830 
          30,509 
                 -
                     -     (2,674,440)     (2,674,440)
          51,038 
                   -
          51,038 

Balance at December 31, 2003 

     10,489,849  $   10,490  $ 17,289,910   $    (174,385)   $  8,625,958  $ 25,751,973 

See accompanying notes.

43

 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
COMPUTER PROGRAMS AND SYSTEMS, INC. 

Statements of Cash Flows 

Operating Activities 
Net income 
Adjustments to net income: 
     Provision for bad debt 
     Deferred taxes 
     Deferred compensation 
     Depreciation 
Changes in operating assets and liabilities: 
     Accounts receivable 
     Financing receivables 
     Inventories 
     Prepaid expenses 
     Accounts payable 
     Deferred revenue 
 Sales, income and use taxes payable 
 Other liabilities 
 Income taxes payable 

Year ended December 31, 

2003 

2002 

2001 

$        7,865,830 

$  10,649,793 

  $   8,680,200 

             256,790 
               33,297 
               51,038 
          1,461,039 

         818,327 
      (1,006,470) 
           29,773 
      1,128,454 

          225,236 
                      -
                      -
          954,543 

             425,307 
             275,007 
             513,251 
              (36,851)
            (967,478)
            (713,929)
         (1,219,856)
             366,868 
            (313,571)

      (5,309,371) 
         (413,430) 
         (488,959) 
         (131,257) 
      1,060,463 
         746,686 
         (621,386) 
         335,199 
         193,546 

        (580,347)
     (1,129,187)
              3,839 
             96,641 
        (207,049)
          186,926 
          486,335 
          269,865 
                      -

Net cash provided by operating activities 

          7,996,742 

      6,991,368 

       8,987,002 

Investing Activities 
Purchases of property and equipment 

         (1,982,520)

      (1,920,750) 

     (1,321,948)

Net cash used in investing activities 

         (1,982,520)

      (1,920,750) 

     (1,321,948)

Financing Activities 
Proceeds from issuance of common stock, net of expenses 
Principal payments on note payable 
Dividends paid 
Distributions to S corporation shareholders 

               30,509 
                         -
         (2,674,440)
            (250,000)

    16,895,596 
         (749,897) 
                      - 
    (16,882,508) 

                      -
          (79,559)
                      -
     (6,600,000)

Net cash used in financing activities 

         (2,893,931)

         (736,809) 

     (6,679,559)

Increase in cash and cash equivalents 

          3,120,291 

      4,333,809 

          985,495 

Cash and cash equivalents at beginning of year 

          6,352,452 

      2,018,643 

        1,033,148 

Cash and cash equivalents at end of year 

$        9,472,743 

$    6,352,452 

  $   2,018,643 

Supplemental disclosure of cash flow information 
Cash paid for interest 
Cash paid for income taxes 

$                      -
        5,331,218 

$         23,677 
    2,783,740 

  $        75,742 
                  -

See accompanying notes. 

44

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
COMPUTER PROGRAMS AND SYSTEMS, INC. 
NOTES TO FINANCIAL STATEMENTS 
DECEMBER 31, 2003 

1. BASIS OF PRESENTATION 

Computer Programs and Systems, Inc. (CPSI or the Company) is a healthcare information technology 
solutions provider which was formed and commenced operations in 1979.  The Company provides, on an 
integrated basis, enterprise-wide clinical management, access management, patient financial management, 
health information management, strategic decision support, resource planning management and enterprise 
application integration solutions to healthcare organizations throughout the United States. Additionally, 
CPSI provides other information technology solutions including outsourcing, remote hosting, networking 
technologies and other related services.  

2. PUBLIC OFFERING OF COMMON STOCK AND RECAPITALIZATION 

On May 24, 2002, the Company successfully completed an initial public offering of 3.0 million shares of 
common stock at a price of $16.50 per share.  Of the shares offered, 1.2 million shares were sold by the 
Company and 1.8 million shares were sold by selling stockholders.  In addition, the underwriters for the 
Company exercised their over-allotment option by purchasing an additional 450,000 shares at $16.50 per 
share from selling stockholders.  Of the net proceeds to the Company of approximately $16.9 million, 
approximately $14.3 million was used to fund a partial distribution to pre-IPO stockholders of previously 
taxed S corporation income, and the balance was used to repay outstanding debt and for general corporate 
purposes.  

On May 1, 2002, the Company declared a 430-for-1 stock split, and on May 6, 2002, the Company 
amended its Articles of Incorporation to increase the Company’s total authorized shares to 10,000,000 
and to change the par value to $0.001 per share.  All share and per share amounts for all periods presented 
in the accompanying financial statements have been restated to reflect the split. 

Effective immediately prior to the completion of the offering, the Company reincorporated in Delaware.  
As a Delaware corporation, the Company now has 30,000,000 shares of authorized common stock with a 
par value per share of $0.001.  

3. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES  

Cash and Cash Equivalents 

Cash and cash equivalents consists of highly-liquid financial instruments, primarily cash and money 
market funds, purchased with an original maturity of three months or less. 

Inventories 

Inventories are stated at cost using the average cost method. The Company’s inventories are composed of 
computer equipment, forms and supplies. 

45

 
 
 
 
 
 
 
 
 
 
 
 
 
 
Property and Equipment 

Property and equipment is recorded at cost, less accumulated depreciation. Additions and improvements 
to property and equipment that materially increase productive capacity or extend the life of an asset are 
capitalized. Maintenance, repairs and minor renewals are expensed as incurred. Upon retirement or other 
disposition of such assets, the related costs and accumulated depreciation are removed from the respective 
accounts and any resulting gain or loss is included in the results of operations.  

Depreciation expense is computed using the straight-line method over the asset’s useful life, generally 5 
years. The Company reviews for the possible impairment of long-lived assets whenever events or changes 
in circumstances indicate that the carrying amount of an asset may not be recoverable. 

Deferred Revenue 

Deferred revenue represents amounts received from customers under licensing agreements and 
implementation fees for which the revenue earnings process has not been completed. 

Revenue Recognition 

Systems sales revenues are derived from the sale of information systems (including software, conversion 
and installation services, hardware, peripherals, forms and office supplies) to new customers and from the 
sale of new or additional products to existing customers.  The Company recognizes revenue from systems 
sales on a completed contract basis in accordance with American Institute of Certified Public Accountants 
Statement of Position (SOP) 97-2, Software Revenue Recognition, and SOP 81-1, Accounting for 
Performance of Construction Type and Certain Production-Type Contracts.  A contract is regarded as 
substantially complete when all hardware and software is installed and the system is operating as 
intended.  Losses are recorded for the entire estimated loss on the contract in the period that it becomes 
evident that current estimates of total contract revenue and contract costs indicate a loss. 

The Company does not record revenue upon execution of a sales contract.  Each customer initially remits 
a non-refundable 10% deposit that is recorded as deferred revenue.  The customer then pays 40% of the 
purchase price when the Company commences training on-site at the customer’s facility.  When the 
system becomes operational, the Company bills the remaining 50% of the system purchase price and 
recognizes revenue for the total amount of the purchase price.  Costs relating to system sales revenues are 
deferred and recognized at the time the related revenues are recognized; however, at December 31, 2003 
and 2002, no system sales-related costs were deferred as all contracts were deemed to be substantially 
complete, or such amounts were not considered to be material. Revenues derived from installation of 
additional software applications are generally recognized upon installation.  Revenues from the sale of 
hardware are recognized upon the shipment of the product to the customer. 

The Company also derives revenues from the provision of system support services, including software 
application support, hardware maintenance, continuing education and related services.  Support services 
are provided pursuant to a General Support Agreement under which the Company provides 
comprehensive system support and related services in exchange for a monthly fee based on the services 
provided.  These contracts range in duration from 1 to 7 years, with an average duration of 5 years, and 
renew automatically unless terminated by the customer.  Revenues from support services are recognized 
in the month when these services are performed.   

As part of system sales, the Company also provides services to some customers as an application service 
provider (ASP) for a monthly fee.  In addition, the Company offers Internet services (ISP) to customers 

46

 
 
 
 
 
 
 
 
 
 
 
for a monthly fee.  Revenues from ASP and ISP services are recognized in the month when these services 
are performed. 

Outsourcing services are sold pursuant to one-year customer agreements, with automatic one-year 
renewals. Revenues from outsourcing services are recognized when services are performed.   

Stock Based Compensation 

During 2002, the Company adopted the 2002 Stock Option Plan, and in accordance with the disclosure 
provisions of SFAS No. 123, Accounting for Stock-Based Compensation, the Company has elected to 
follow APB No. 25, Accounting for Stock Issued to Employees and related interpretations in accounting 
for employee stock options. Under APB No. 25, because the exercise price of the Company’s employee 
stock options equals the market price of the underlying stock on the date of grant, no compensation 
expense was reflected in net income for the year ended December 31, 2003 or 2002.  Had the Company 
accounted for its stock-based compensation plan based on the fair value of awards at grant date, 
consistent with the methodology of SFAS No. 123, the Company’s reported net income and income per 
share for the years ended December 31, 2003 and 2002 would have been impacted as indicated below.  
There were no employee stock options granted during the year ended December 31, 2003.  The effects of 
applying SFAS No. 123 on a pro forma basis for the year ended December 31, 2003, are not likely to be 
representative of the effects on reported pro forma net income for future years as options vest over several 
years and it is anticipated that additional grants will be made in future years. 

Net income as reported 
Deduct: Total stock-based employee 
compensation expense determined under the 
fair value method for all awards 

 December 31, 

2003 

2002 

$7,865,830 

$10,649,793 

(192,168)

     (117,436) 

Pro forma net income 

$7,673,662 

$10,532,357 

Diluted income per share as reported 

Pro forma diluted income per share 

$0.75

$0.73

$1.06 

$1.05 

Research and Development Costs 

Research and development costs are expensed as incurred.  Research and development costs totaled 
approximately $1,143,000, $1,104,000 and $888,000 for the years ended December 31, 2003, 2002 and 
2001, respectively. 

Software Development Costs 

According to Statement of Financial Accounting Standards (SFAS) No. 86, Accounting for the Costs of 
Computer Software to be Sold, Leased or Otherwise Marketed, all costs incurred to establish the 
technological feasibility of a computer software product to be sold, leased or otherwise marketed are 
research and development costs and are charged to expense during the period when the costs are incurred. 
Costs incurred subsequent to establishing technological feasibility are capitalized. Capitalization of 
computer software costs ceases when the product is available for general release to customers. The 

47

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Company has determined that costs to be capitalized based on SFAS No. 86 are not material.  Software 
and development costs of approximately $189,000, $104,000 and $168,000 were charged to expense 
during the years ended December 31, 2003, 2002 and 2001, respectively. 

Advertising 

Advertising costs are expensed as incurred. Advertising expense was approximately $307,000, $373,000 
and $377,000 for the years ended December 31, 2003, 2002 and 2001, respectively. 

Shipping and Handling Costs 

Shipping and handling costs are expensed as incurred.  Shipping and handling costs totaled approximately 
$764,000, $664,000 and $377,000 for the years ended December 31, 2003, 2002 and 2001, respectively. 

Use of Estimates 

The preparation of financial statements in conformity with accounting principles generally accepted in the 
United States requires that management make estimates and assumptions that affect the reported amounts 
of assets and liabilities, the disclosures of contingent assets and liabilities at the date of the financial 
statements and the reported revenues and expenses during the reporting periods. Actual results could 
differ from those estimates. 

Impact of Recently Issued Accounting Standards 

In June 2001, the FASB issued SFAS No. 143, Accounting for Asset Retirement Obligations.  SFAS No. 
143 addresses financial accounting and reporting for obligations associated with the retirement of tangible 
long-lived assets and the associated asset retirement costs.  It applies to legal obligations associated with 
the retirement of long-lived assets that result from the acquisition, construction, development and/or the 
normal operation of a long-lived asset, except for certain obligations of lessees.  The adoption of this 
standard in 2003 did not have any effect on the Company’s financial position, results of operations or 
cash flows. 

In August 2001, the FASB issued SFAS No. 144, Accounting for the Impairment or Disposal of Long-
Lived Assets.  SFAS No. 144 addresses financial accounting and reporting for the impairment or disposal 
of long-lived assets.  The adoption of this standard in 2002 did not have any effect on the Company’s 
financial position, results of operations or cash flows. 

In July 2002, the FASB issued SFAS No. 146, Accounting for Costs Associated with Exit or Disposal 
Activities. SFAS No. 146 addresses significant issues regarding the recognition, measurement and 
reporting of costs that are associated with exit and disposal activities, including restructuring activities 
that are currently accounted for pursuant to the guidance set forth in EITF No. 94-3, Liability Recognition 
for Certain Employee Termination Benefits and Other Costs to Exit an Activity. SFAS No. 146 revises the 
accounting for certain lease termination costs and employee termination benefits, which are generally 
recognized in connection with restructuring activities. Adoption of this standard in 2003 did not have any 
effect on the Company’s financial position, results of operations or cash flows. 

On December 31, 2002, the FASB issued SFAS No. 148, Accounting for Stock-Based Compensation—
Transition and Disclosure. SFAS No. 148 amends SFAS No. 123, Accounting for Stock-Based 
Compensation, to provide alternative methods of transition to SFAS No. 123’s fair value method of 
accounting for stock-based employee compensation. SFAS No. 148 also amends the disclosure provisions 
of SFAS No. 123 and APB Opinion No. 28, Interim Financial Reporting, to require disclosure in the 
summary of significant accounting policies of the effect’s of an entity’s accounting policy with respect to 

48

 
 
 
 
 
 
 
 
 
 
 
 
 
stock-based compensation. While the Statement does not amend SFAS No. 123 to require companies to 
account for employee stock options using the fair value method, the disclosure provisions of SFAS No. 
148 are applicable to all companies with stock-based employee compensation, regardless of whether they 
account for that compensation using the fair value method of SFAS No. 123 or the intrinsic value method 
of Opinion 25.  The Company adopted the disclosure requirement of this standard in 2002. 

In January 2003, the FASB issued Interpretation 46 (FIN46), Consolidation of Variable Interest Entities. 
In general, a variable interest entity is a corporation, partnership, trust, or any other legal structure used 
for business purposes that either (a) does not have equity investors with voting rights or (b) has equity 
investors that do not provide sufficient financial resources for the entity to support its activities. FIN 46 
requires a variable interest entity to be consolidated by a company if that company is subject to a majority 
of the risk of loss from the variable interest entity's activities or entitled to receive a majority of the 
entity's residual returns or both. The consolidation requirements of FIN 46 apply immediately to variable 
interest entities created after January 31, 2003. The consolidation requirements apply to transactions 
entered into prior to February 1, 2003 in the first fiscal year or interim period beginning after June 15, 
2003. Certain of the disclosure requirements apply in all financial statements issued after January 31, 
2003, regardless of when the variable interest entity was established. The adoption of FIN 46 on July 1, 
2003 did not have an impact on our financial statements.  

In December 2003, the FASB issued Interpretation 46R (FIN 46R), a revision to FIN 46, Consolidation of 
Variable Interest Entities. FIN 46R clarifies some of the provisions of FIN 46 and exempts certain entities 
from its requirements. FIN 46R is effective at the end of the first interim period ending after March 15, 
2004. Entities that have adopted FIN 46 prior to this effective date can continue to apply the provisions of 
FIN 46 until the effective date of FIN 46R. As noted above, CPSI adopted FIN 46 on July 1, 2003 and it 
did not have an impact on our financial statements. The early adoption of FIN46R did not have an impact 
on our financial statements. 

In April 2003, the FASB issued SFAS 149, Amendment of Statement 133 on Derivative Instruments and 
Hedging Activities, which amends and clarifies accounting for derivative instruments, including certain 
derivative instruments embedded in other contracts, and for hedging activities under SFAS 133. The 
statement is effective (with certain exceptions) for contracts entered into or modified after June 30, 2003. 
This statement will not have an impact on our financial statements.  

In May 2003, the FASB issued SFAS 150, Accounting for Certain Financial Instruments with 
Characteristics of both Liabilities and Equity. The statement establishes standards for how an issuer 
classifies and measures certain financial instruments with characteristics of both liabilities and equity. It 
requires that an issuer classify a financial instrument that is within its scope as a liability (or an asset in 
some circumstances). It is effective for financial instruments entered into or modified after May 31, 2003, 
and otherwise is effective at the beginning of the first interim period beginning after June 15, 2003. This 
statement will not have an impact on our financial statements. 

4.  NET INCOME PER SHARE 

Pro forma net income per share consists of the Company’s historical net income as an S corporation, 
adjusted for additional income taxes that would have been recorded had the Company operated as a C 
corporation for the entire period presented.  The Company presents both basic and diluted earnings per 
share (EPS) amounts. Basic EPS is calculated by dividing net income by the weighted average number of 
common shares outstanding during the period presented. Diluted EPS amounts are based upon the 
weighted average number of common and common equivalent shares outstanding during the period 
presented. The difference between basic and diluted EPS is solely attributable to stock options. The 
Company uses the treasury stock method to calculate the impact of outstanding stock options. For the 
years ended December 31, 2003 and 2002, these dilutive shares were 48,523 and 37,327, respectively.  

49

 
 
 
 
   
   
 
 
Since the Company’s first award under its’ stock compensation plan was in 2002, there were no dilutive 
shares for the year ended December 31, 2001. 

5. INCOME TAXES   

The financial statements of the Company do not include a provision for income taxes through May 20, 
2002 because the taxable income of the Company was included in the income tax returns of the 
shareholders under the S corporation election through that date. Upon completion of the IPO, the 
Company’s S corporation status was terminated, and the Company became subject to federal and state 
income taxes. Upon revocation of the S corporation election, the Company recorded a $934,000 credit to 
the deferred tax provision. Prior to its termination as an S corporation, the Company declared a 
distribution of earned, but undistributed, accumulated S corporation earnings through the date the 
Company became a C corporation. A partial distribution in the amount of $12,750,000 was paid on May 
28, 2002. An additional distribution of $1,532,510 was made during the fourth quarter of 2002. During 
2003, a final distribution of $250,000, representing the remaining balance due, was paid to pre-IPO 
stockholders. 

The Company provides for income taxes using the liability method in accordance with SFAS No. 109, 
Accounting for Income Taxes. Deferred income taxes arise from the temporary differences in the 
recognition of income and expenses for tax purposes. Deferred tax assets and liabilities are comprised of 
the following at December 31, 2003 and 2002: 

Deferred tax assets: 
   Accounts receivable 
   Sales, income and use tax receivables 
   Sales, income and use tax interest 
   Accrued liabilities 

Deferred tax liabilities: 
   Deferred compensation 

2003 

2002 

$  328,253 
        15,149 
                 -
    696,037 

$    217,558 
        74,229 
      213,986 
      586,358 

 1,039,439 

   1,092,131 

(66,266)

(85,661) 

Net deferred tax assets 

$  973,173 

$ 1,006,470 

Significant components of the income tax provision (benefit) for the year ended December 31, 2003 and 
2002 are as follows: 

Current provision: 
     Federal  
     State 
Deferred provision: 
     Federal 
     State 

2003 

2002 

$ 4,339,486 
      644,864 

$ 2,575,944 
      401,342 

        29,793 
          3,504 

    (900,526) 
    (105,944) 

Total income tax provision 

$ 5,017,647 

$ 1,970,816 

50

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The difference between income taxes at the U. S. federal statutory income tax rate of 35% and those 
reported in the statement of income for the years ended December 31, 2003 and 2002 are as follows: 

Income taxes at U. S. Federal statutory rate 
   State income tax, net of federal tax effect 
   Impact of graduated tax rates 
   S corporation 
   Change in tax status 
   Other 

2003 

2002 

$ 4,509,217 
      427,923 
(100,000)
                   -
                   -
        180,507 

$ 4,417,213 
      259,869 
(100,000) 
 (1,657,622) 
    (934,262) 
        (14,382) 

$ 5,017,647 

$ 1,970,816 

6.  DEFERRED COMPENSATION 

On May 17, 2002, Kenny Muscat, one of the Company’s directors and a principal stockholder sold 
66,667 shares of common stock to J. Boyd Douglas, Jr., one of the Company’s directors and its Chief 
Operating Officer (COO), for a price of $13.20 per share. The share price was determined by an 
independent valuation of the fair market value of the shares. A promissory note was delivered for the 
entire purchase price. The promissory note bears interest at the applicable rate for federal income tax 
purposes, and the entire principal balance is due five years after the date of the stock sale. As a part of the 
same transaction, Mr. Muscat also transferred to Mr. Douglas 19,333 shares of common stock for $1.00. 
These shares are subject to a mandatory transfer obligation under which Mr. Douglas will be required to 
transfer the shares back to Mr. Muscat in the event Mr. Douglas’ employment with the Company 
terminates for certain reasons prior to the fifth anniversary of the transaction date. The mandatory transfer 
obligation will lapse as to 20% of the shares on each anniversary of the transaction date over the five year 
restriction period. 

As a result of this transaction, the Company recorded deferred compensation expense of $255,196, 
representing the excess of the fair market value of the 19,333 shares transferred by Mr. Muscat to Mr. 
Douglas. The Company is amortizing the deferred compensation expense over 20 fiscal quarters, 
recognizing pre-tax compensation expense of $12,760 per quarter. 

7.  STOCK OPTION PLAN 

Under the 2002 Stock Option Plan, the Company has authorized the issuance of equity-based awards for 
up to 1,165,333 shares of common stock to provide additional incentive to employees and officers. 
Pursuant to the plan, the Company can grant either incentive or non-qualified stock options. Options to 
purchase common stock under the 2002 Stock Option Plan have been granted to Company employees 
with an exercise price equal to the fair market value of the underlying shares on the date of grant. 

Stock options granted under the 2002 Stock Option Plan to executive officers of the Company become 
vested as to all of the shares covered by such grant on the fifth anniversary of the grant date and expire on 
the seventh anniversary of the grant date. Stock options granted under the 2002 Stock Option Plan to 
employees other than executive officers become vested as to 50% of the shares covered by the option 
grant on the third anniversary of the grant date and as to 100% of such shares on the fifth anniversary of 
the grant date, and such options expire on the seventh anniversary of the grant date. 

Under the methodology of SFAS No. 123, the fair value of the Company’s stock options was estimated at 
the date of grant using the Black-Scholes option pricing model. The multiple option approach was used, 

51

 
 
 
 
 
 
 
 
 
 
 
with assumptions for expected option life of 5 years and 44% expected volatility for the market price of 
the Company’s stock in 2002. An estimated dividend yield of 3% was used. The risk-free rate of return 
was determined to be 2.79% in 2002.  

The Black-Scholes option valuation model was developed for use in estimating the fair value of traded 
options which have no vesting restrictions and are fully transferable. In addition, option valuation models 
require the input of highly subjective assumptions, including expected stock price volatility. Because the 
Company’s employee stock options have characteristics significantly different from those of traded 
options, and because subjectivity of assumptions can materially affect estimate of fair value, the 
Company believes the Black-Scholes model does not necessarily provide a reliable single measure of the 
fair value of its employee stock options.  

The weighted average grant date fair value of options granted to employees under the 2002 Stock Option 
Plan during 2002 was $5.30. During 2002, options were granted under the plan at exercise prices equal to 
the market value of the Company’s stock on the date of grant.  

A summary of stock option activity under the plan is as follows: 

2003 

  Exercise 

2002 

  Exercise 

Shares 

Price 

Shares 

Price 

Beginning of year 

    444,998 

 $            –

                – 

 $            –

Granted 
Exercised 
Forfeited 

                –
       (1,849)
     (18,390)

         –
        16.50 
        16.50 

    466,133 
                – 
     (21,135) 

           16.50 
         –
           16.50 

End of year 

    424,759 

$      16.50 

    444,998 

   $      16.50 

Exercisable  

           312 

$      16.50 

                – 

 $            –

Shares available for future grants under 
the plan as of December 31, 2003 

    738,725 

       720,335 

Weighted-average grant date fair value 

$        5.30 

   $        5.30 

Weighted-average remaining contractual life 

5.5 years

6.5 years

8. CONCENTRATION OF CREDIT RISK 

Financial instruments, which potentially subject the Company to concentration of credit risk, consist 
principally of temporary cash investments and trade receivables. The Company places its temporary cash 
investments with credit-worthy, high-quality financial institutions.  

The Company’s customer base is concentrated in the healthcare industry. Customers are located 
throughout the United States. The Company requires no collateral or other security to support customer 

52

 
 
 
 
 
 
 
 
 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
receivables. An allowance for doubtful accounts has been established for potential credit losses based on 
historical collection experience.   

9. FAIR VALUES OF FINANCIAL INSTRUMENTS 

Cash, cash equivalents, accounts receivable, accounts payable and accrued liabilities are reflected in the 
accompanying financial statements at cost, which approximates fair value because of the short-term 
maturity of these instruments. Based on the borrowing rates currently available to the Company for bank 
loans with similar terms and average maturities, at December 31, 2003 and 2002 the fair values of the 
note payable and financing receivables approximate book value.  

10. FINANCING RECEIVABLES 

The Company leases its information and patient care systems to certain healthcare providers under sales-
type leases expiring in various years through 2007.  These receivables typically have terms from 2 to 5 
years, bear interest at various rates, and are usually collateralized by a security interest in the underlying 
assets.  Since the Company has a history of successfully collecting all amounts due under the original 
payment terms of these extended payment arrangements without making any concessions to its customers, 
the Company satisfies the requirement of SOP 97-2 for revenue recognition.  The Company’s history with 
these types of extended payment term arrangements supports management’s assertion that revenues are 
fixed and determinable and probable of collection.   

The components of these lease receivables were as follows on December 31: 

Total minimum lease payments receivable 

$       1,690,917 

  $     1,637,908 

2003 

2002 

Less unearned income 

Lease receivables 

Less current portion 

Amounts due after one year 

         (232,867)

          (222,649)

        1,458,050 

         1,415,259 

         (665,947)

         (574,656)

$         792,103 

  $        840,603 

Future minimum lease payments to be received at December 31, 2003 are as follows: 

2004 

2005 

2006 

2007 

2008 

Total minimum lease payments to be received 

Less unearned income 

Net leases receivable 

53

  $        751,773 

            443,896 

            294,876 

            132,666 

              67,706 

         1,690,917 

          (232,867)

  $     1,458,050 

 
 
 
 
 
 
 
 
 
 
 
 
The Company has also sold information and patient care systems to certain healthcare providers under 
extended payment terms.  These receivables, included in current portion of financing receivables, 
typically have terms from 3 to 12 months and are collateralized by a security interest in the underlying 
assets.  Total amounts receivable under these arrangements at December 31, 2003 and 2002 were 
$448,595 (of which $1,768 is included as a long-term asset) and $766,391, respectively. 

11. BENEFIT PLANS 

In January 1994, the Company adopted the Computer Programs & System, Inc. 401(k) Retirement Plan 
that covers all eligible employees of the Company who have completed one year of service. The plan 
allows eligible employees to contribute up to 15% of their pre-tax earnings up to the statutory limit 
prescribed by the Internal Revenue Service.  The Company matches the first $1,000 contribution per 
participant plus a discretionary amount determined by the Company. The Company contributed 
approximately $935,000, $816,000 and $739,000 to the plan for the years ended December 31, 2003, 
2002 and 2001, respectively. 

The Company provides certain health and medical benefits to eligible employees, their spouses and 
dependents pursuant to a benefit plan funded by the Company. Each participating employee contributes to 
the Company's costs associated with such benefit plan. The Company's obligation to fund this benefit plan 
and pay for these benefits is limited through the Company's purchase of an insurance policy from a third-
party insurer. The amount established as a reserve is intended to recognize the Company's estimated 
obligations with respect to its payment of claims and claims incurred but not yet reported under the 
benefit plan. Management believes that the recorded liability for medical self-insurance at December 31, 
2003 and 2002 is adequate to cover the losses and claims incurred, but these reserves are necessarily 
based on estimates and the amount ultimately paid may be more or less than such estimates.  

12. OPERATING LEASES 

The Company leases certain real property, all of which is owned by entities that are owned by one or 
more stockholders of the Company. The lease agreements have terms of ten years and expire on or before 
June 2013. For the second five years of the leases, the rental may be adjusted with consent of the landlord 
and the Company. If mutual consent cannot be obtained, the rental for the second five years will remain 
the same as the first five years.  For the years ended December 31, 2003, 2002 and 2001, total rent 
expense paid to related parties was approximately $1,325,000, $1,112,000 and $958,000, respectively.   

The future minimum lease payments payable under operating leases subsequent to December 31, 2003 are 
as follows: 

2004 

2005 

2006 

2007 

2008 

Thereafter 

$   1,365,275 

     1,365,275 

    1,365,275 

    1,365,275 

    1,365,275 

    4,605,150 

$ 11,431,525 

54

 
 
 
 
 
 
 
 
 
 
13.  SUBSEQUENT EVENT 

On February 3, 2004, the Company announced a dividend for the first quarter of 2004 in the amount of 
$0.12 per share.   

14.  QUARTERLY FINANCIAL STATEMENTS (UNAUDITED) 

The following table presents a summary of our results of operations for our eight most recent quarters 
ended December 31, 2003.  The information for each of these quarters is unaudited and has been prepared 
on a basis consistent with the audited financial statements.  This information includes all adjustments, 
consisting only of normal recurring adjustments, we consider necessary for fair presentation of this 
information when read in conjunction with the audited financial statements and related notes.  Pro forma 
net income and pro forma net income per share data included in this table has been adjusted to include pro 
forma corporate income tax provisions as if we had been a C corporation during all of the quarterly 
periods.  Our operating results have varied on a quarterly basis and may fluctuate significantly in the 
future.  

Year Ended December 31, 2003 

 Sales revenues 
 Gross profit 
 Operating income 
 Net income 
 Net income per share 
 Basic 
 Diluted 
 Weighted average shares 
outstanding 
 Basic 
 Diluted 

Year Ended December 31, 2002 

 Sales revenues 
 Gross profit 
 Operating income 
 Net income 
 Net income per share 
 Basic 
 Diluted 
 Pro forma net income 
 Pro forma net income per share 
 Basic 
 Diluted 
 Weighted average shares 
outstanding 
 Basic 
 Diluted 

  1st Quarter  2nd Quarter(1)

3rd Quarter 

4th Quarter 

(in thousands except for share and per share data) 

$     20,075 
8,037 
3,224 
2,071 

$    19,908 
8,320 
3,308 
2,112 

$     19,591 
7,319 
2,278 
1,461 

 $     21,729 
9,223 
3,735 
2,222 

0.20 
0.20 

0.20 
0.20 

0.14 
0.14 

0.21 
0.21 

10,488,000 
10,569,223 

10,488,000 
10,543,577 

10,488,000 
10,524,832 

10,488,181 
10,510,879 

$     16,921 
7,019 
2,799 
2,872 

$    17,511 
7,199 
2,763 
3,316 

$     18,897 
7,905 
3,041 
2,077 

 $     20,416 
8,696 
3,466 
2,385 

0.31 
0.31 
1,790 

0.19 
0.19 

0.34 
0.34 
1,792 

0.18 
0.18 

0.20 
0.20 
2,077 

0.20 
0.20 

0.23 
0.23 
2,385 

0.23 
0.23 

9,288,000 
9,288,000 

9,815,473 
9,829,027 

10,488,000 
10,589,226 

10,488,000 
10,563,331 

The 2nd Quarter 2002 information was restated to record a $934,000 tax benefit arising from the Company’s 

(1)  
change in tax status that occurred on May 21, 2002, the date of the IPO. 

55

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
SCHEDULE II 
COMPUTER PROGRAMS AND SYSTEMS, INC. 
VALUATION AND QUALIFYING ACCOUNTS AND RESERVES 

(1) 
Additions 
charged to 
cost and 
expenses 

Balance at 
beginning of 
period 

(2)       

Deductions  

Balance at end 
of period 

2001 
2002 
2003 

$ 479,000 
  532,000 
  768,000 

$ 225,000 
  818,000 
  257,000 

 $   172,000 
      582,000 
      121,000 

$ 532,000 
  768,000 
  904,000 

Description 

Allowance for doubtful accounts  
deducted from accounts 
receivable in the balance sheet 

(1) Adjustments to allowance for change in 
estimates. 
(2) Uncollectible accounts written off, net of 
recoveries. 

ITEM 9. 

CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON 
ACCOUNTING AND FINANCIAL DISCLOSURE 

None. 

ITEM 9A.  

CONTROLS AND PROCEDURES. 

Our management, under the supervision and with the participation of our Chief Executive Officer 
and Chief Financial Officer, has evaluated the effectiveness of the design and operation of the Company’s 
disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)), as of the 
end of the period covered by this report.  Based upon that evaluation, the Chief Executive Officer and 
Chief Financial Officer concluded that the Company’s disclosure controls and procedures are effective in 
timely alerting them to material information relating to the Company that is required to be included in our 
periodic Securities and Exchange Commission filings.  

There have not been any changes in the Company’s internal control over financial reporting (as 

defined in Exchange Act Rules 13a-15(f) and 15(d)-15(f)) during the fourth quarter of 2003 that have 
materially affected, or are reasonably likely to materially affect, the Company’s internal control over 
financial reporting. 

56

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
PART III 

ITEM 10. 

DIRECTORS AND EXECUTIVE OFFICERS OF THE REGISTRANT 

We have adopted a Code of Business Conduct and Ethics applicable to all of our directors, 

officers (including our Chief Executive Officer and senior financial officers) and employees.  We have 
also adopted a separate code of ethics with additional guidelines and responsibilities applicable to our 
Chief Executive Officer and senior financial officers, known as the Code of Ethics for CEO and Senior 
Financial Officers.  Copies of the Code of Business Conduct and Ethics and the Code of Ethics for CEO 
and Senior Financial Officers are filed as exhibits to this Annual Report on Form 10-K. 

Other information required by this Item regarding Executive Officers is included in Part I of this 
Form 10-K under the caption "Executive Officers" in accordance with Instruction 3 of the Instructions to 
Paragraph (b) of Item 401 of Regulation S-K. 

Other information required by this Item is incorporated by reference pursuant to General 
Instruction G(3) of Form 10-K from CPSI's definitive Proxy Statement for the 2004 Annual Meeting of 
Stockholders to be filed with the Securities and Exchange Commission pursuant to Regulation 14A. 

ITEM 11. 

EXECUTIVE COMPENSATION  

The information required by this Item is incorporated by reference pursuant to General 
Instruction G(3) of Form 10-K from CPSI's definitive Proxy Statement for the 2004 Annual Meeting of 
Stockholders to be filed with the Securities and Exchange Commission pursuant to Regulation 14A. 

ITEM 12. 

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND 
MANAGEMENT AND RELATED STOCKHOLDER MATTERS 

Certain of the information required by this Item is incorporated by reference pursuant to General 

Instruction G(3) of Form 10-K from CPSI's definitive Proxy Statement for the 2004 Annual Meeting of 
Stockholders to be filed with the Securities and Exchange Commission pursuant to Regulation 14A. 

The following table summaries the securities that have been authorized for issuance under our 

2002 Stock Option Plan, which is described in Note 7 of the Notes to the Financial Statements. 

Equity Compensation Plan Information 

Number of securities 
to be issued 
upon exercise of 
outstanding options, 
warrants and rights 
(a) 

Weighted-average 
exercise price of 
outstanding options, 
warrants and rights 
(b) 

Number of securities 
remaining available for 
future issuance under 
equity compensation plans 
(excluding securities 
reflected in column (a)) 
(c) 

424,759 

$16.50 

738,725 

-0- 
424,759 

N/A 

-0- 
738,725 

57

Plan Category 

Equity compensation  
     plans approved by  
     stockholders 

Equity compensation  
     plans not approved  
     by stockholders 
                  Total 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
ITEM 13. 

CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS 

The information required by this Item is incorporated by reference pursuant to General 
Instruction G(3) of Form 10-K from CPSI's definitive Proxy Statement for the 2004 Annual Meeting of 
Stockholders to be filed with the Securities and Exchange Commission pursuant to Regulation 14A. 

ITEM 14.  

PRINCIPAL ACCOUNTANT FEES AND SERVICES 

The information required by this Item is incorporated by reference pursuant to General 
Instruction G(3) of Form 10-K from CPSI's definitive Proxy Statement for the 2004 Annual Meeting of 
Stockholders to be filed with the Securities and Exchange Commission pursuant to Regulation 14A. 

58

 
 
 
 
 
 
ITEM 15. 

EXHIBITS, FINANCIAL STATEMENT SCHEDULES AND REPORTS ON 
FORM 8-K. 

PART IV 

(a)(1) and (2) and (d) - Financial Statements and Financial Statement Schedules. 

Financial Statements:  The Financial Statements and related Financial Statements 
Schedule of CPSI are included herein in Part II, Item 8.   

(b) 

Reports on Form 8-K. 

On October 22, 2003 a report on Form 8-K was furnished to the SEC pursuant to 
Item 12 on Form 8-K. 

(c) 

Exhibits. 

The exhibits listed on the Exhibit Index on page 65 of this Form 10-K are filed 
herewith or are incorporated herein by reference. 

59

 
 
 
 
 
 
 
 
 
SIGNATURES 

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the 

registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly 
authorized, on this the 12th day of March, 2004. 

COMPUTER PROGRAMS AND SYSTEMS, INC. 

By: 

/s/ David A. Dye 
David A. Dye 
President and Chief Executive Officer 

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed 
below by the following persons on behalf of the Registrant and in the capacities and on the dates indicated. 

Name 

Title 

Date 

/s/ John Morrissey 
John Morrissey 

/s/ David A. Dye 
David A. Dye 

/s/ J. Boyd Douglas 
J. Boyd Douglas 

 /s/ M. Stephen Walker 
M. Stephen Walker 

/s/ Darrell G. West 
Darrell G. West 

/s/ Dennis P. Wilkins 
Dennis P. Wilkins 

/s/ M. Kenny Muscat 
M. Kenny Muscat 

/s/ Ernest F. Ladd, III 
Ernest F. Ladd, III 

/s/ W. Austin Mulherin, III 
W. Austin Mulherin, III 

/s/ William R. Seifert, II 
William R. Seifert, II 

Chairman of the Board and 
Director 

President, Chief Executive Officer 
and Director (principal executive 
officer) 

  March 9, 2003 

March 12, 2003 

Executive Vice President,  
Chief Operating Officer and Director 

March 12, 2003 

Vice President - Finance and  
Chief Financial Officer 

March 12, 2003 

Controller (principal accounting 
officer) 

March 12, 2003 

Director 

Director 

Director 

Director 

Director 

March 9, 2003 

March 11, 2003 

March 11, 2003 

March 10, 2003 

March 9, 2003 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
      
 
 
 
 
 
 
 
 
 
 
 
 
 
Exhibit 
Number  

Description 

Exhibit Index 

3.1 

3.2 

10.1 

Certificate of Incorporation (filed as Exhibit 3.4 to CPSI’s Registration Statement on 
Form   S-1 (Registration No. 333-84726) and incorporated herein by reference) 

Bylaws (filed as Exhibit 3.6 to CPSI’s Registration Statement on Form S-1 
(Registration No. 333-84726) and incorporated herein by reference) 

Real Property Lease, dated April 1, 2002, between CPSI and CP Investments, Inc. (filed 
as Exhibit 10.1 to CPSI’s Registration Statement on Form S-1 (Registration 
No. 333-84726) and incorporated herein by reference) 

10.2         

Real Property Lease dated April 1, 2002, between CPSI and DJK, LLC (filed as Exhibit 
10.2 to CPSI’s Registration Statement on Form S-1 (Registration No. 333-84726) and 
incorporated herein by reference) 

10.3 

10.4 

10. 5 

10.6 

10.7  

10.8  

10.9  

10.10  

2002 Stock Option Plan (filed as Exhibit 10.3 to CPSI’s Registration Statement on Form 
S-1 (Registration No. 333-84726) and incorporated herein by reference) 

Form of Non-Qualified Stock Option Agreement for executive officers (filed as Exhibit 
10.4 to CPSI’s Registration Statement on Form S-1 (Registration No. 333-84726) and 
incorporated herein by reference) 

Agreement, dated July 1, 1999, between CPSI, AmSouth Bank and certain shareholders 
and officers of CPSI (filed as Exhibit 10.5 to CPSI’s Registration Statement on Form S-1 
(Registration No. 333-84726) and incorporated herein by reference) 

Agreement, dated May 18, 2001, between CPSI, AmSouth Bank and certain shareholders 
and officers of CPSI (filed as Exhibit 10.6 to CPSI’s Registration Statement on Form S-1 
(Registration No. 333-84726) and incorporated herein by reference) 

Release and Termination Agreement, dated April 26, 2002, between CPSI, AmSouth 
Bank and certain shareholders and officers of CPSI (filed as Exhibit 10.7 to CPSI’s 
Registration Statement on Form S-1 (Registration No. 333-84726) and incorporated 
herein by reference) 

Release and Termination Agreement, dated April 26, 2002, between CPSI, AmSouth 
Bank, Dennis P. Wilkins and certain officers of CPSI (filed as Exhibit 10.8 to CPSI’s 
Registration Statement on Form S-1 (Registration No. 333-84726) and incorporated 
herein by reference) 

Form of Indemnity Agreement entered into by CPSI and each of its non-employee 
directors (filed as Exhibit 10.1 to CPSI’s Quarterly Report on Form 10-Q for the period 
ended September 30, 2002 and incorporated herein by reference) 

Real Property Lease, dated October 1, 2002, between CPSI and CP Investments, Inc. 
(filed as Exhibit 10.10 to CPSI’s Annual Report on Form 10-K for the period ended 
December 31, 2002 and incorporated herein by reference) 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
10.11  

Real Property Lease, dated November 1, 2002, between CPSI and CP Investments, Inc. 
(filed as Exhibit 10.11 to CPSI’s Annual Report on Form 10-K for the period ended 
December 31, 2002 and incorporated herein by reference) 

10.12  

Real Property Lease, dated June 16, 2003, between CPSI and CP Investments, Inc. 

14.1 

14.2  

23.1 

31.1     

31.2     

32.1  

32.2  

Code of Business Conduct and Ethics 

Code of Ethics for CEO and Senior Financial Officers 

Consent of Ernst & Young LLP, Independent Auditors 

Certification of the Chief Executive Officer pursuant to Rule 13a-14(a)/15d-14(a), as adopted 
pursuant to Section 302 of the Sarbanes-Oxley Act of 2002  

Certification of the Chief Financial Officer pursuant to Rule 13a-14(a)/15d-14(a), as adopted 
pursuant to Section 302 of the Sarbanes-Oxley Act of 2002  

Certification of the Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as 
adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 

Certification of the Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as 
adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 

 
 
 
 
 
 
 
 
   
 
 
 
 
Directors and Officers

Board of Directors

David A. Dye
President and Chief Executive Officer
Computer Programs and Systems, Inc.

Ernest F. Ladd, III
Retired Executive Vice President and 

M. Kenny Muscat
Retired Executive Vice President and

Chief Financial Officer

Dravo Corporation

Chief Operating Officer

Computer Programs and Systems, Inc.

J. Boyd Douglas, Jr.
Executive Vice President and 
Chief Operating Officer

John W. Morrissey
Retired Vice President, Sales 

Computer Programs and Systems, Inc.

and Marketing

Computer Programs and Systems, Inc.

W. Austin Mulherin, III
Attorney
Frazer, Greene, Upchurch & 
Baker, LLC

William R. Seifert, II
Executive Vice President
AmSouth Bank

Dennis P. Wilkins
Retired President and 

Chief Executive Officer

Computer Programs and Systems, Inc.

Officers

David A. Dye
President and Chief Executive Officer

J. Boyd Douglas, Jr.
Executive Vice President and 
Chief Operating Officer 

M. Stephen Walker
Vice President of Finance and 
Chief Financial Officer

Corporate Data

Independent Accountants
Ernst & Young LLP
1901 Sixth Avenue North
Suite 1900, AmSouth/Harbert Plaza
Birmingham, AL 35203-2618

Transfer Agent
Wachovia Bank, N.A.
Equity Services Group
1525 West W. T Harris Blvd., 3C3
Charlotte, NC 28262-1153

Legal Counsel
Maynard, Cooper & Gale, P.C.
1901 Sixth Avenue North
Suite 2400, AmSouth/Harbert Plaza
Birmingham, AL 35203-2618

Corporate Headquarters
Computer Programs and Systems, Inc.
6600 Wall Street
Mobile, AL  36695
(251) 639-8100
www.cpsinet.com

Common Stock
Computer Programs and Systems,
Inc.’s common stock is traded on
The NASDAQ Stock Market’s
National Market under the symbol
CPSI.  

C

CPSI

6600 Wall Street
Mobile, AL  36695